Raymund Roos
Professor emeritus Neurology
- Name
- Prof.dr. R.A.C. Roos
- Telephone
- +31 71 526 9111
- r.a.c.roos@lumc.nl
- ORCID iD
- 0000-0001-5591-1133
Raymund AC Roos became MD in 1977 and defended his PhD thesis in 1984. The topic of his thesis was Nuclear Membrane Indentations in Huntington disease, an electron microscopical study. Initially as head of the outpatient department of the LUMC in Leiden he managed a movement disorder clinic with the focus on Huntington disease (HD). He participated in several clinical trials in HD. Since 1993 as head of the department he focussed on HD only. He was supervisor of 20 HD PhD thesis out of more than 50 PhD students. He has over 200 international publications on HD as (co)author out of 400 and author of several bookchapters. He is since 2004 site-investigator for Registry of the European Huntington Disease Network of the largest site in Europe. From 2014 he is PI of Enroll-HD in Leiden. He is site PI of TRACK-HD, the international collaboration in the search for biomarkers. He is active in the board of the EHDN and secretary general of the research Committee on Huntington disease of the World Federation of Neurology. From 1992 till 2014 he was responsible for the resident training in Leiden and was responsible for the new framework for the residence program in Neurology for the Netherlands: NEURON. In april 2015 the 6th edition of the book Neurology for medical students was published where he was co-director.
Professor emeritus Neurology
- Faculteit Geneeskunde
- Divisie 3
- Neurologie
Contact
- Bakels, H.S.; Feleus, S.; Rodríguez-Girondo, M.; Losekoot, M.; Bijlsma, E.K.; Roos, R.A.C. & Bot, S.T. de (2024), Prevalence of Juvenile-Onset and pediatric Huntington's Disease and their availability and ability to participate in trials , Journal of Huntington's Disease 13(3): 357-368.
- Estevez-Fraga, C.; Altmann, A.; Parker, C.S.; Scahill, R.; Costa, B.; Chen, Z.B.; Manzoni, C.; Zarkali, A.; Durr, A.; Roos, R.A.C.; Landwehrmeyer, B.; Leavitt, B.R.; Rees, G.; Tabrizi, S.J. & McColgan, P. (2023), Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration, Brain 146(11): 4532-4546.
- Kalkers, K.; Schols, J.M.G.A.; Zwet, E.W. van & Roos, R.A.C. (2022), Dysphagia, fear of choking and preventive measures in patients with Huntington's disease, The journal of nutrition, health & aging 26(4): 332-338.
- Zwaan, K.F. van der; Mentink, M.D.C.; Jacobs, M.; Roos, R.A.C. & Bot, S.T. de (2022), Huntington?s disease influences employment before and during clinical manifestation: A systematic review, Parkinsonism & Related Disorders 96: 100-108.
- Feleus, S.; Schaijk, M. van; Roos, R.A.C. & Bot, S.T. de (2022), The Many Faces of Huntington's Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review, Journal of Personalized Medicine 12(4).
- Bird, T.D.; Lange, H.; Cruickshank, T.; Dose, M.; Eddy, C.; Oosterloo, M.; Paulsen, J.S.; Reilmann, R.; Rickards, H.; Roos, R.A.C. & Weindl, A. (2022), Reader Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
- Dekker, L.; Venema, E.; Pirson, F.A.V.; Majoie, C.B.L.M.; Emmer, B.J.; Jansen, I.G.H.; Mulder, M.J.H.L.; Lemmens, R.; Goldhoorn, R.J.B.; Wermer, M.J.H.; Boiten, J.; Nijeholt, G.J.L.A.; Roos, Y.B.W.E.M.; Es, A.C.G.M. van; Lingsma, H.F.; Dippel, D.W.J.; Zwam, W.H. van; Oostenbrugge, R.J. van; Wijngaard, I.R. van den & MR CLEAN Registry investigators (2021), Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well, Stroke and Vascular Neurology 6(4): 572-580.
- Dirikgil, E.; Roos, R.; Groeneveld, G.H.; Heringhaus, C.; Silven, A.V.; Petrus, A.H.J.; Villalobos-Quesada, M.; Tsonaka, R.; Boog, P.J.M.V.; Rabelink, T.J.; Bos, W.J.W.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2021), Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project.
- Bernsen, M.L.E.; Kauw, F.; Martens, J.M.; Lugt, A. van der; Yo, L.S.F.; Walderveen, M.A.A. van; Roos, Y.B.W.E.M.; Worp, H.B. van der; Dankbaar, J.W.; Hofmeijer, J. & MR CLEAN Registry Investigators (2021), Malignant infarction after endovascular treatment: Incidence and prediction, International Journal of Stroke.
- Treurniet, K.M.; LeCouffe, N.E.; Kappelhof, M.; Emmer, B.J.; Es, A.C.G.M. van; Boiten, J.; Lycklama, G.J.; Keizer, K.; Yo, L.S.F.; Lingsma, H.F.; Zwam, W.H. van; Ridder, I. de; Oostenbrugge, R.J. van; Lugt, A. van der; Dippel, D.W.J.; Coutinho, J.M.; Roos, Y.B.W.E.M.; Majoie, C.B.L.M. & MR CLEAN-NO IV Investigators (2021), MR CLEAN-NO IV: intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion-study protocol for a randomized clinical trial, Trials 22(1).
- Venema, E.; Roozenbeek, B.; Mulder, M.J.H.L.; Brown, S.; Majoie, C.B.L.M.; Steyerberg, E.W.; Demchuk, A.M.; Muir, K.W.; Davalos, A.; Mitchell, P.J.; Bracard, S.; Berkhemer, O.A.; Nijeholt, G.J.L.A.; Oostenbrugge, R.J. van; Roos, Y.B.W.E.M.; Zwam, W.H. van; Lugt, A. van der; Hill, M.D.; White, P.; Campbell, B.C.V.; Guillemin, F.; Saver, J.L.; Jovin, T.G.; Goyal, M.; Dippel, D.W.J.; Lingsma, H.F.; HERMES Collaborators & MR CLEAN Registry Investigators (2021), Prediction of outcome and endovascular treatment benefit validation and update of the MR PREDICTS decision tool, Stroke 52(9): 2764-2772.
- Kalkers, K.; Schols, J.M.G.A.; Zwet, E.W. van & Roos, R.A.C. (2021), Falls, Fear of Falling, and Preventive Measures in Huntington's Disease: The Perspectives of Individuals with Huntington's Disease and Caregivers in Long-Term Care, Journal of Huntington's Disease 10(4): 493-503.
- Mansoor, N.M.; Vanniyasingam, T.; Malone, I.; Hobbs, N.Z.; Rees, E.; Durr, A.; Roos, R.A.C.; Landwehrmeyer, B.; Tabrizi, S.J.; Johnson, E.B. & Scahill, R.I. (2021), Validating automated segmentation tools in the assessment of caudate atrophy in Huntington's disease, Frontiers in Neurology 12.
- Luijten, S.P.R.; Compagne, K.C.J.; Es, A.C.G.M. van; Roos, Y.B.W.E.M.; Majoie, C.B.L.M.; Oostenbrugge, R.J. van; Zwam, W.H. van; Dippel, D.W.J.; Wolters, F.J.; Lugt, A. van der; Bos, D. & MR CLEAN Trial Investigators (2021), Brain atrophy and endovascular treatment effect in acute ischemic stroke, International Journal of Stroke.
- Bakels, H.S.; Roos, R.A.C.; Roon-Mom, W.M.C. van & Bot, S.T. de (2021), Juvenile-onset Huntington disease pathophysiology and neurodevelopment, Movement Disorders 37(1).
- Zwaan, K.F. van der; Jacobs, M.; Zwet, E.W. van; Roos, R.A.C. & Bot, S.T. de (2021), Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study, Journal of Huntington's Disease 10(2): 269-276.
- Samuels, N.; Graaf, R.A. van de; Berg, C.A.L. van den; Venema, S.M.U.; Bala, K.; Doormaal, P.J. van; Steen, W. van der; Witvoet, E.; Boiten, J.; Hertog, H. den; Schonewille, W.J.; Hofmeijer, J.; Schreuder, F.; Schreuder, T.A.H.C.M.L.; Worp, H.B. van der; Roos, Y.B.W.E.M.; Majoie, C.B.L.M.; Burke, J.F.; Es, A.C.G.M. van; Lugt, A. van der; Roozenbeek, B.; Lingsma, H.F.; Dippel, D.W.J. & MR CLEAN Registry Investigators (2021), Blood pressure in the first 6 hours following endovascular treatment for ischemic stroke is associated with outcome, Stroke 52(11): 3514-3522.
- Mutluer, F.O.; Velde, N. van der; Voorneveld, J.; Bosch, J.G.; Roos-Hesselink, J.W.; Geest, R.J. van der; Hirsch, A. & Bosch, A. van den (2021), Evaluation of intraventricular flow by multimodality imaging: a review and meta-analysis, Cardiovascular Ultrasound 19(1).
- Meenen, L.C.C. van; Hartog, S.J. den; Groot, A.E.; Emmer, B.J.; Smeekes, M.D.; Siegers, A.; Kommer, G.J.; Majoie, C.B.L.M.; Roos, Y.B.W.E.M.; Es, A.C.G.M. van; Dippel, D.W.; Worp, H.B. van der; Lingsma, H.F.; Roozenbeek, B.; Coutinho, J.M. & MR CLEAN Registry Investigators (2021), Relationship between primary stroke center volume and time to endovascular thrombectomy in acute ischemic stroke, European Journal of Neurology 28(12): 4031-4038.
- Estevez-Fraga, C.; Scahill, R.I.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Langbehn, D.R.; Rees, G.; Gregory, S. & Tabrizi, S.J. (2021), Composite UHDRS correlates with progression of imaging biomarkers in Huntington's disease, Movement Disorders 36(5): 1259-1264.
- Andrews, S.C.; Langbehn, D.R.; Craufurd, D.; Durr, A.; Leavitt, B.R.; Roos, R.A.; Tabrizi, S.J.; Stout, J.C. & TRACK-HD Investigators (2021), Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease, Psychological Medicine 51(8): 1338-1344.
- Sprenger, G.P.; Roos, R.A.C.; Zwet, E. van; Reijntjes, R.H.; Achterberg, W.P. & Bot, S.T. de (2021), The prevalence of pain in Huntington’s Disease in a large worldwide cohort , Parkinsonism & Related Disorders 89(aug 1): 73-78.
- Oosterloo, M.; Greef, B.T.A. de; Bijlsma, E.K.; Durr, A.; Tabrizi, S.J.; Estevez-Fraga, C.; Die-Smulders, C.E.M. de & Roos, R.A.C. (2021), Disease onset in Huntington's disease, Movement Disorders Clinical Practice 8(3): 352-360.
- Diemen, M.P.J. van; Hart, E.P.; Hameeteman, P.W.; Coppen, E.M.; Winder, J.Y.; Heijer, J. den; Moerland, M.; Kan, H.; Grond, J. van der; Webb, A.; Roos, R.A.C. & Groeneveld, G.J. (2020), Brain Bio-Energetic State Does Not Correlate to Muscle Mitochondrial Function in Huntington's Disease, Journal of Huntington's Disease 9(4): 335-344.
- Oosterloo, M.; Bijlsma, E.K.; Verschuuren-Bemelmans, C.C.; Schouten, M.I.; Die-Smulders, C. de & Roos, R.A.C. (2020), Predictive genetic testing in Huntington's disease, European Journal of Human Genetics 28(9): 1205-1209.
- Heffels, J.C.F.; Everink, I.H.J.; Oosterloo, M.; Roos, R.A.C. & Schols, J.M.G.A. (2020), Measuring the quality of care in nursing home residents with early-onset neurodegenerative diseases: a scoping review, BMC Palliative Care 19(1).
- Gregory, S.; Lohse, K.R.; Johnson, E.B.; Leavitt, B.R.; Durr, A.; Roos, R.A.C.; Rees, G.; Tabrizi, S.J.; Scahill, R.I. & Orth, M. (2020), Longitudinal structural MRI in neurologically healthy adults, Journal of Magnetic Resonance Imaging 52(5): 1385-1399.
- Aziz, N.A.; Roos, R.A.C. & Pijl, H. (2020), Insulin sensitivity in De Novo Parkinson's disease, Movement Disorders 35(9).
- Oosterloo, M.; Bijlsma, E.K.; Die-Smulders, C. de & Roos, R.A.C. (2020), Diagnosing juvenile Huntington's disease, Brain Sciences 10(3).
- Fazio, P.; Fitzer-Attas, C.J.; Mrzljak, L.; Bronzova, J.; Nag, S.; Warner, J.H.; Landwehrmeyer, B.; Al-Tawil, N.; Halldin, C.; Forsberg, A.; Ware, J.; Dilda, V.; Wood, A.; Sampaio, C.; Varrone, A.; Svenningsson, P.; Paucar, M.; Sundblom, J.; Nyholm, D.; Widner, H.; Heiberg, A.; Frich, J.; Nielsen, J.; Hjermind, L.; Roos, R.; PEARL-HD Collaborator & LONGPDE10 Study Collaborator (2020), PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression, Movement Disorders 35(4): 606-615.
- Diemen, M.P.J. van; Hart, E.P.; Abbruscato, A.; Mead, L.; Beelen, I. van; Bergheanu, S.C.; Hameeteman, P.W.; Coppen, E.; Winder, J.Y.; Moerland, M.; Kan, H.; Grond, J. van der; Webb, A.; Roos, R.A.C. & Groeneveld, G.J. (2020), Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study, British Journal of Clinical Pharmacology 87.
- Gregory, S.; Odish, O.F.F.; Mayer, I.; Mills, J.; Johnson, E.B.; Scahill, R.I.; Rothwell, J.; Rees, G.; Long, J.D.; Tabrizi, S.J.; Roos, R.A.C. & Orth, M. (2019), Multimodal characterization of the visual network in Huntington's disease gene carriers, Clinical Neurophysiology 130(11): 2053-2059.
- Sprenger, G.P.; Zwaan, K.F. van der; Roos, R.A.C. & Achterberg, W.P. (2019), The prevalence and the burden of pain in patients with Huntington disease: a systematic review and meta-analysis, PAIN 160(4): 773-783.
- Gardiner, S.L.; Trompet, S.; Sabayan, B.; Boogaard, M.W.; Jukema, J.W.; Slagboom, P.E.; Roos, R.A.C.; Grond, J. van der & Aziz, N.A. (2019), Repeat variations in polyglutamine disease-associated genes and cognitive function in old age, Neurobiology of Aging 84.
- Gardiner, S.L.; Mutsert, R. de; Trompet, S.; Boogaard, M.W.; Dijk, K.W. van; Jukema, P.J.W.; Slagboom, P.E.; Roos, R.A.C.; Pijl, H.; Rosendaal, F.R. & Aziz, N.A. (2019), Repeat length variations in polyglutamine disease-associated genes affect body mass index, International Journal of Obesity 43(3): 440-449.
- Gardiner, S.L.; Harder, A.V.E.; Campman, Y.J.M.; Trompet, S.; Gussekloo, J.; Belzen, M.J. van; Boogaare, M.W.; Roos, R.A.C.; Jansen, I.E.; Pijnenburg, Y.A.L.; Scheltens, P.; Flier, W.M. van der & Aziz, N.A. (2019), Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer's disease, Neurobiology of Aging 73.
- Gardiner, S.L.; Boogaard, M.W.; Trompet, S.; Mutsert, R. de; Rosendaal, F.R.; Gussekloo, J.; Jukema, J.W.; Roos, R.A.C. & Aziz, N.A. (2019), Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease-Associated Alleles Among Large Population-Based Cohorts, JAMA Neurology 76(6): 650-656.
- Jacobs, M.; Hart, E.P.; Miranda, Y.M.; Groeneveld, G.J.; Gerven, J.M.A. van & Roos, R.A.C. (2019), Predictors of simulated driving performance in Huntington's disease, Parkinsonism and Related Disorders 60: 64-69.
- Winder, J.Y.; Achterberg, W.P.; Gardiner, S.L. & Roos, R.A.C. (2019), Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease, European Journal of Neurology 26(5): 780-785.
- Quarrell, O.W.J.; Nance, M.A.; Nopoulos, P.; Reilmann, R.; Oosterloo, M.; Tabrizi, S.J.; Furby, H.; Saft, C.; Roos, R.A.C.; Squitieri, F.; Landwehrmeyer, G.B.; Burgunder, J.M. & European Huntington Dis Network (2019), Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?, Movement Disorders 34(4): 584-585.
- Jacobs, M.; Zwaan, K.F. van der; Hart, E.P.; Groeneveld, G.J. & Roos, R.A.C. (2019), Comparable rates of simulator sickness in Huntington's disease and healthy individuals, Transportation Research Part F: Traffic Psychology and Behaviour 60: 499-504.
- Muller, H.P.; Huppertz, H.J.; Dreyhaupt, J.; Ludolph, A.C.; Tabrizi, S.J.; Roos, R.A.C.; Durr, A.; Landwehrmeyer, G.B. & Kassubek, J. (2019), Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials, Parkinsonism and Related Disorders 63: 179-184.
- Langbehn, D.R.; Stout, J.C.; Gregory, S.; Mills, J.A.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Long, J.D.; Owen, G.; Johnson, H.J.; Borowsky, B.; Craufurd, D.; Reilmann, R.; Landwehrmeyer, G.B.; Scahill, R.I.; Tabrizi, S.J.; Acharya, T.; Andrews, S.; Arran, N.; Axelson, E.; Bardinet, E.; Bechtel, N.; Berna, C.; Bohlen, S.; Callaghan, J.; Cassidy, A.; Coleman, A.; Crawford, H.; Santos, R.D.; Decolongon, J.; Dumas, E.; Fan, M.N.; Frost, C.; Ghosh, R.; Gibbard, C.; Hensman-Moss, D.; Hobbs, N.; Jauffret, C.; Johnson, E.; Jones, R.; Jurgens, C.; Justo, D.; Keogh, R.; Koren, T.; Labuschagne, I.; Lahiri, N.; Lehericy, S.; Malone, I.; Marelli, C.; McColgan, P.; Nigaud, K.; O'Regan, A.; Papoutsi, M.; Pepple, T.; Petkau, T.; Queller, S.; Read, J.; Say, M.; Schoonderbeek, A.; Stopford, C.; Sturrock, A.; Hart, E. 't; Valabregue, R.; Bogaard, S. van den; Grond, J. van der; Wang, C.C.; Weber, N.; Whitehead, D.; Witjes-Ane, M.N. & TRACK-HD Track-On HD Grps (2019), Association of CAG Repeats With Long-term Progression in Huntington Disease, JAMA Neurology 76(11): 1375-1385.
- Odish O, Gregory S, Mayer I, Mills J, Johnson E, Scahill R, Rothwell J, Rees G, Long J, Tabrizi S, Roos R & Orth M (2019), Multimodal characterization of the visual network in Huntington's disease, Movement Disorders 34: S14-S15.
- Ciosi, M.; Maxwell, A.; Cumming, S.A.; Moss, D.J.H.; Alshammari, A.M.; Flower, M.D.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Holmans, P.; Jones, L.; Langbehn, D.R.; Kwak, S.; Tabrizi, S.J.; Monckton, D.G.; TRACK-HD Team & Enroll-HD Team (2019), A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes, EBioMedicine 48: 568-580.
- Coppen, E.M.; Jacobs, M.; Zwaan, K.F. van der; Middelkoop, H.A.M. & Roos, R.A.C. (2019), Visual Object Perception in Premanifest and Early Manifest Huntington's Disease, ARCHIVES OF CLINICAL NEUROPSYCHOLOGY 34(8): 1320-1328.
- Braisch, U.; Muche, R.; Rothenbacher, D.; Landwehrmeyer, G.B.; Long, J.D.; Orth, M.; Bachoud-Levi, A.C.; Bentivoglio, A.R.; Biunno, I.; Bonelli, R.M.; Burgunder, J.M.; Dunnett, S.B.; Ferreira, J.J.; Handley, O.J.; Heiberg, A.; Illmann, T.; Landwehrmeyer, G.B.; Levey, J.; Ramos-Arroyo, M.; Nielsen, J.E.; Koivisto, S.P.; Paivarinta, M.; Roos, R.A.C.; Sebastian, A.R.; Tabrizi, S.J.; Vandenberghe, W.; Verellen-Dumoulin, C.; Uhrova, T.; Wahlstrom, J.; Zaremba, J.; Baake, V.; Barth, K.; Bos, R.; Come, A.; Guedes, L.C.; Finisterra, A.M.; Garde, M.B.; Bos, R.; Betz, S.; Callaghan, J.; Capodarca, S.; Wildson, S.C.; Silva, V. da; Renzo, M. di; Ecker, D.; Finisterra, M.; Fullam, R.; Genoves, C.; Gilling, M.; Handley, O.J.; Hvalstedt, C.; Held, C.; Koppers, K.; Lamanna, C.; Laura, M.; Descals, A.M.; Martinez-Horta, S.; Mestre, T.; Minster, S.; Monza, D.; Mutze, L.; Oehmen, M.; Padieu, H.; Paterski, L.; Peppa, N.; Koivisto, S.P.; Rindal, B.; Roren, N.; Sasinkova, P.; Seliverstov, Y.; Timewell, E.; Townhill, J.; Cubillo, P.T.; Walsem, M.R. van; Witjes-Ane, M.N.; Witkowski, G.; Wright, A.; Yudina, E.; Zielonka, D.; Zielonka, E.; Zinzi, P.; Braunwarth, E.M.; Brugger, F.; Buratti, L.; Hametner, E.M.; Hepperger, C.; Holas, C.; Hotter, A.; Hussl, A.; Larcher, B.; Mahlknecht, P.; Muller, C.; Pinter, B.; Poewe, W.; Seppi, K.; Sprenger, F.; Wenning, G.; Dupuis, M.; Minet, C.; Ribai, P.; Paemel, D. van; Verellen-Dumoulin, C.; Klempir, J.; Majerova, V.; Roth, J.; Babiloni, B.; Debruxelles, S.; Duche, C.; Goizet, C.; Jameau, L.; Lafoucriere, D.; Spampinato, U.; Bachoud-Levi, A.C.; Boisse, M.F.; Langavant, L.C. de; Lemoine, L.; Morgado, G.; Youssov, K.; Annic, A.; Barthelemy, R.; Bruycker, C. de; Cabaret, M.; Carette, A.S.; Carriere, N.; Decorte, E.; Defebvre, L.; Delliaux, M.; Delval, A.; Depelchin, A.; Destee, A.; Dewulf-Pasz, N.; Dondaine, T.; Dugauquier, F.; Dujardin, K.; Krystkowiak, P.; Lemaire, M.H.; Manouvrier, S.; Peter, M.; Plomhause, L.; Sablonniere, B.; Simonin, C.; Tard, C.; Thibault-Tanchou, S.; Vuillaume, I.; Bellonet, M.; Benoit, A.; Blin, S.; Courtin, F.; Duru, C.; Fasquel, V.; Godefroy, O.; Krystkowiak, P.; Mantaux, B.; Roussel, M.; Tir, M.; Schuler, B.; Wannepain, S.; Azulay, J.P.; Chabot, C.; Delfini, M.; Eusebio, A.; Fluchere, F.; Grosjean, H.; Mundler, L.; Nowak, M.; Bioux, S.; Bliaux, E.; Girard, C.; Guyant-Marechal, L.; Hannequin, D.; Hannier, V.; Jourdain, S.; Maltete, D.; Pouliquen, D.; Blondeau, L.; Calvas, F.; Cheriet, S.; Delabaere, H.; Demonet, J.F.; Pariente, J.; Pierre, M.; Beuth, M.; Gelderblom, H.; Priller, J.; Pruss, H.; Spruth, E.; Thiel, S.; Ellrichmannberlin, G.; Herrmann, L.; Hoffmann, R.; Kaminski, B.; Saft, C.; Bosredon, C.; Hunger, U.; Lohle, M.; Maass, A.; Ossig, C.; Schmidt, S.; Storch, A.; Wolz, A.; Wolz, M.; Kohl, Z.; Kozay, C.; Ullah, J.; Winkler, J.; Bergmann, U.; Boringer, R.; Capetian, P.; Kammel, G.; Lambeck, J.; Meier, S.; Rijntjes, M.; Zucker, B.; Boelmans, K.; Ganos, C.; Goerendt, I.; Heinicke, W.; Hidding, U.; Lewerenz, J.; Munchau, A.; Orth, M.; Schmalfeld, J.; Stubbe, L.; Zittel, S.; Diercks, G.; Dressler, D.; Francis, F.; Gayde-Stephan, S.; Gorzolla, H.; Kramer, B.; Minschke, R.; Schrader, C.; Tacik, P.; Longinus, B.; Lusebrink, A.; Muhlau, M.; Peinemann, A.; Stadtler, M.; Weindl, A.; Winkelmann, J.; Ziegler, C.; Bechtel, N.; Beckmann, H.; Bohlen, S.; Gopfert, N.; Holzner, E.; Lange, H.; Reilmann, R.; Rohm, S.; Rumpf, S.; Sass, C.; Schepers, S.; Weber, N.; Barth, K.; Buck, A.; Connemann, J.; Ecker, D.; Geitner, C.; Held, C.; Kesse, A.; Landwehrmeyer, B.; Lezius, F.; Lewerenz, J.; Nepper, S.; Niess, A.; Orth, M.; Schneider, A.; Schwenk, D.; Sussmuth, S.; Trautmann, S.; Weydt, P.; Klebe, S.; Musacchio, T.; Leypold, C.; Noth, K.; Cormio, C.; Tommaso, M. de; Franco, G.; Sciruicchio, V.; Serpino, C.; Calandra-Buonaura, G.; Capellari, S.; Cortelli, P.; Gallassi, R.; Poda, R.; Sambati, L.; Scaglione, C.; Maserati, M.S.; Agosti, C.; Barlati, S. & Composte (2019), Identification of symbol digit modality test score extremes in Huntington's disease, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180(3): 232-245.
- Scahill Rachael I., Johnson Eileanoir B., Byrne Lauren, Gregory Sarah, Rodrigues Filipe B., Blennow Kaj, Durr Alexandra, Leavitt Blair R., Roos Raymund A., Zetterberg Henrik, Tabrizi Sarah J. & Wild Edward J. (2018), NEUROFILAMENT LIGHT PROTEIN IN BLOOD PREDICTS REGIONAL ATROPHY IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 89: A34-A35.
- McColgan, P.; Gregory, S.; Seunarine, K.K.; Razi, A.; Papoutsi, M.; Johnson, E.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Holmans, P.; Scahill, R.I.; Clark, C.A.; Rees, G.; Tabrizi, S.J. & Track-On HD Investigators (2018), Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes, Biological Psychiatry 83(5): 456-465.
- Jacobs, M.; Hart, E.P. & Roos, R.A.C. (2018), Cognitive Performance and Apathy Predict Unemployment in Huntington's Disease Mutation Carriers, Journal of Neuropsychiatry and Clinical Neurosciences 30(3): 188-193.
- Valcarcel-Ocete, L.; Fullaondo, A.; Alkorta-Aranburu, G.; Garcia-Barcina, M.; Roos, R.A.C.; Hjermind, L.E.; Saft, C.; Frontali, M.; Reilmann, R.; Rickards, H.; Zubiaga, A.M.; Aguirre, A. & REGISTRY Invest European Huntingto (2018), Does arterial hypertension influence the onset of Huntington's disease?, PLoS ONE 13(5).
- Roon-Mom, W.M.C. van; Roos, R.A.C. & Bot, S.T. de (2018), Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients, Nucleic Acid Therapeutics 28(2): 59-62.
- Baake, V.; Duijn, E. van & Roos, R.A.C. (2018), Huntington's Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy, Journal of Neuropsychiatry and Clinical Neurosciences 30(3): 183-187.
- Winder, J.Y.; Roos, R.A.C.; Burgunder, J.M.; Marinus, J. & Reilmann, R. (2018), Interrater Reliability of the Unified Huntington's Disease Rating Scale-Total Motor Score Certification, Movement Disorders Clinical Practice 5(3): 290-295.
- Winder, J.Y.; Achterberg, W.P. & Roos, R.A.C. (2018), Marriage as Protector for Nursing Home Admission in Huntington's Disease, Journal of Huntington's Disease 7(3): 263-269.
- Byrne Lauren M., Rodrigues Filipe B., Blennow Kaj, Durr Alexandra, Leavitt Blair R., Roos Raymund A. C., Scahill Rachael I., Tabrizi Sarah J., Zetterberg Henrik, Langbehn Douglas & Wild Edward J. (2018), Neurofilament Light Chain in Blood as a Predictor of Onset, Progression, and Brain Atrophy in Huntington's Disease: A Longitudinal Cohort Analysis, Neurotherapeutics 15(1): 236-237.
- Winder, J.Y. & Roos, R.A.C. (2018), Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice, PLoS ONE 13(3).
- Gregory, S.; Long, J.D.; Kloppel, S.; Razi, A.; Scheller, E.; Minkova, L.; Johnson, E.B.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Mills, J.A.; Stout, J.C.; Scahill, R.I.; Tabrizi, S.J.; Rees, G. & Track-On Investigators (2018), Testing a longitudinal compensation model in premanifest Huntington's disease, Brain 141: 2156-2166.
- Zielonka, D.; Ren, M.; Michele, G. de; Roos, R.A.C.; Squitieri, F.; Bentivoglio, A.R.; Marcinkowski, J.T. & Landwehrmeyer, G.B. (2018), The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease, Parkinsonism and Related Disorders 49: 42-47.
- Coppen, E.M.; Grond, J. van der; Hart, E.P.; Lakke, E.A.J.F. & Roos, R.A.C. (2018), The visual cortex and visual cognition in Huntington's disease: An overview of current literature, Behavioural Brain Research 351: 63-74.
- Minkova, L.; Gregory, S.; Scahill, R.I.; Abdulkadir, A.; Kaller, C.P.; Peter, J.; Long, J.D.; Stout, J.C.; Reilmann, R.; Roos, R.A.; Durr, A.; Leavitt, B.R.; Tabrizi, S.J.; Kloppel, S. & TRACK-HD Investigators (2018), Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease, NeuroImage: Clinical 17: 312-324.
- McNulty, P.; Pilcher, R.; Ramesh, R.; Necuiniate, R.; Hughes, A.; Farewell, D.; Holmans, P.; Jones, L. & REGISTRY Investigators European Hu (2018), Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study, Journal of Huntington's Disease 7(3): 209-222.
- Andrews, S.C.; Craufurd, D.; Durr, A.; Leavitt, B.R.; Roos, R.A.; Tabrizi, S.J.; Stout, J.C. & Track-HD Investigators (2018), Executive Impairment Is Associated With Unawareness of Neuropsychiatric Symptoms in Premanifest and Early Huntington's Disease, Neuropsychology 32(8): 958-965.
- Coppen Emma M., Hafkemeijer Anne, van der Grond Jeroen, Wolf Jurriaan J. H. Barkey & Roos Raymund A. C. (2018), STRUCTURE AND FUNCTION OF THE POSTERIOR CEREBRAL CORTEX IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 89: A36-A37.
- Coppen, E.M.; Grond, J. van der; Hafkemeijer, A.; Wolf, J.J.H.B. & Roos, R.A.C. (2018), Structural and functional changes of the visual cortex in early Huntington's disease, Human Brain Mapping 39(12): 4776-4786.
- Odish, O.F.F.; Reijntjes, R.H.A.M.; Bogaard, S.J.A. van den; Roos, R.A.C. & Leemans, A. (2018), Progressive microstructural changes of the occipital cortex in Huntington's disease, Brain Imaging and Behavior 12(6): 1786-1794.
- Byrne Lauren M., Rodrigues Filipe B., Blennow Kai, Durr Alexandra, Leavitt Blair R., Roos Raymund A. C., Scahill Rachael I., Tabrizi Sarah J., Zetterberg Henrik, Langbehn Douglas & Wild Edward J. (2018), NEUROFILAMENT LIGHT PROTEIN IN BLOOD AS A POTENTIAL BIOMARKER OF NEURODEGENERATION IN HUNGTINGTON'S DISEASE: A RETROSPECTIVE COHORT ANALYSIS, Journal of Neurology, Neurosurgery and Psychiatry 89: A33-A34.
- Gregory, S.; Crawford, H.; Seunarine, K.; Leavitt, B.; Durr, A.; Roos, R.A.C.; Scahill, R.I.; Tabrizi, S.J.; Rees, G.; Langbehn, D. & Orth, M. (2018), Natural biological variation of white matter microstructure is accentuated in Huntington's disease, Human Brain Mapping 39(9): 3516-3527.
- Kalkers Kristel, Derksen Els, Neyens Jacques C. L., Schols Jos M. G. A. & Roos Raymund A. C. (2018), FEAR OF CHOKING AND FEAR OF FALLING IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 89: A80-A80.
- Odish, O.F.F.; Johnsen, K.; Someren, P. van; Roos, R.A.C. & Dijk, J.G. van (2018), EEG may serve as a biomarker in Huntington's disease using machine learning automatic classification, Scientific Reports 8.
- Jacobs Milou, Hart Ellen P., Miranda Yuri Mejia, Groeneveld Geert Jan, van Gerven Joop M. A. & Roos Raymund A. C. (2018), DRIVING PERFORMANCE OF HUNTINGTON'S DISEASE GENE CARRIERS, Journal of Neurology, Neurosurgery and Psychiatry 89: A87-A87.
- Gardiner Sarah L., Milanese Chiara, Boogaard Merel W., Buijsen Ronald A. M., Hogenboom Marye, Roos Raymund A. C., Masroberardino Pier G., van Roon-Mom Willeke M. C. & Aziz N. Ahmad (2018), DIFFERENCES IN BIOENERGETIC STATUS IN PATIENT-DERIVED FIBROBLAST CELLS ARE ASSOCIATED WITH AGE OF ONSET IN HUNTINGTON DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 89: A12-A12.
- Gregory Sarah, Long Jeffrey D., Kloppel Stefan, Razi Adeel, Scheller Elisa, Minkova Lora, Johnson Eileanoir B., Durr Alexandra, Roos Raymund A. C., Leavitt Blair R., Mills James A., Stout Julie C., Scahill Rachael I., Tabrizi Sarah J. & Rees Geraint (2018), COMPENSATION IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 89: A39-A40.
- Gardiner, S.L.; Milanese, C.; Boogaard, M.W.; Buijsen, R.A.M.; Hogenboom, M.; Roos, R.A.C.; Mastroberardino, P.G.; Roon-Mom, W.M.C. van & Aziz, N.A. (2018), Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset, Neurology Genetics 4(5).
- Winder Jessica Y., Achterberg Wilco P., Marinus Johan, Gardiner Sarah L. & Roos Raymund A. C. (2018), ASSESSMENT SCALES FOR PATIENTS WITH ADVANCED HUNTINGTON'S DISEASE: COMPARISON OF THE UHDRS AND UHDRS-FAP, Journal of Neurology, Neurosurgery and Psychiatry 89: A60-A60.
- Winder, J.Y.; Achterberg, W.P.; Marinus, J.; Gardiner, S.L. & Roos, R.A.C. (2018), Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS-FAP, Movement Disorders Clinical Practice 5(5): 527-533.
- Baake, V.; Coppen, E.M.; Duijn, E. van; Dumas, E.M.; Bogaard, S.J.A. van den; Scahill, R.I.; Johnson, H.; Leavitt, B.; Durr, A.; Tabrizi, S.J.; Craufurd, D.; Roos, R.A.C. & Track-HD Investigators (2018), Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study, NeuroImage: Clinical 19: 66-70.
- Rowley, C.D.; Tabrizi, S.J.; Scahill, R.I.; Leavitt, B.R.; Roos, R.A.C.; Durr, A. & Bock, N.A. (2018), Altered Intracortical T-1-Weighted/T-2-Weighted Ratio Signal in Huntington's Disease, Frontiers in Neuroscience 12.
- Jacobs, M.; Hart, E.P.; Miranda, Y.M.; Groeneveld, G.J.; Gerven, J.M.A. van & Roos, R.A.C. (2018), Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditions, Traffic Injury Prevention 19(7): 708-714.
- Coppen, E.M.; Jacobs, M.; Berg-Huysmans, A.A. van den; Grond, J. van der & Roos, R.A.C. (2018), Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease, Parkinsonism and Related Disorders 46: 56-61.
- Odish, O.; Reijntjes, R.; Bogaard, S. van den; Roos, R. & Leemans, A. (2017), Progressive microstructural abnormalities of the occipital cortex in Huntington's disease, Movement Disorders 32.
- Sarah L. Gardiner, Martine J. van Belzen, Merel W. Boogaard, Willeke M. C. van Roon-Mom, Maarten P. Rozing, Albert M. van Hemert, Johannes H. Smit, Aartjan T. F. Beekman, Gerard van Grootheest, Robert A. Schoevers, Richard C. Oude Voshaar, Raymund A. C. Roos, Hannie C. Comijs, Brenda W. J. H. Penninx & Roos C. van der Mast and N. Ahmad Aziz (2017), Huntingtin gene repeat size variations affect risk of lifetime depression, Translational Psychiatry 7(12).
- Schobel, S.A.; Palermo, G.; Auinger, P.; Long, J.D.; Ma, S.Y.; Khwaja, O.S.; Trundell, D.; Cudkowicz, M.; Hersch, S.; Sampaio, C.; Dorsey, E.R.; Leavitt, B.R.; Kieburtz, K.D.; Sevigny, J.J.; Langbehn, D.R.; Tabrizi, S.J.; TRACK-HD Huntington Study Grp; COHORT Huntington Study Grp; CARE-HD Huntington Study Grp & 2CARE Huntington Study Grp (2017), Motor, cognitive, and functional declines contribute to a single progressive factor in early HD, Neurology 89(24): 2495-2502.
- Rodrigues, F.B.; Abreu, D.; Damasio, J.; Goncalves, N.; Correia-Guedes, L.; Coelho, M.; Ferreira, J.J. & REGISTRY Investigators European (2017), Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort, Movement Disorders Clinical Practice 4(5): 737-742.
- Zielonka, D.; Ren, M.; Roos, R.A.C.; Michele, G. de; Marcinkowski, J.T.; Squitieri, F.; Bentivoglio, A.R. & Landwehrmeyer, G.B. (2017), How motor, behavioral and cognitive symptoms affect functional abilities in Huntington's disease?, Journal of the Neurological Sciences 381: 1056-1056.
- Braisch, U.; Hay, B.; Muche, R.; Rothenbacher, D.; Landwehrmeyer, G.B.; Long, J.D.; Orth, M.; European Huntington's Dis Network & Huntington Study Grp (2017), Identification of Extreme Motor Phenotypes in Huntington's Disease, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174(3): 283-294.
- Maltby, J.; Dale, M.; Underwood, M.; Simpson, J. & European Huntington's Dis Network (2017), Irritability in Huntington's Disease: Factor Analysis of Snaith's Irritability Scale, Movement Disorders Clinical Practice 4(3): 342-348.
- McColgan, P.; Razi, A.; Gregory, S.; Seunarine, K.K.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Scahill, R.I.; Clark, C.A.; Langbehn, D.R.; Rees, G.; Tabrizi, S.J. & Track On-HD Investigators (2017), Structural and Functional Brain Network Correlates of Depressive Symptoms in Premanifest Huntington's Disease, Human Brain Mapping 38(6): 2819-2829.
- Gardiner, S.L.; Belzen, M.J. van; Boogaard, M.W.; Roon-Mom, W.M.C. van; Rozing, M.P.; Hemert, A.M. van; Smit, J.H.; Beekman, A.T.F.; Grootheest, G. van; Schoevers, R.A.; Voshaar, R.C.O.; Roos, R.A.C.; Comijs, H.C.; Penninx, B.W.J.H.; Mast, R.C. van der & Aziz, N.A. (2017), Huntingtin gene repeat size variations affect risk of lifetime depression, Translational Psychiatry 7.
- Johnson, E.B.; Gregory, S.; Johnson, H.J.; Durr, A.; Leavitt, B.R.; Roos, R.A.; Rees, G.; Tabrizi, S.J. & Scahill, R.I. (2017), Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease, Frontiers in Neurology 8.
- Long, J.D.; Mills, J.A.; Leavitt, B.R.; Durr, A.; Roos, R.A.; Stout, J.C.; Reilmann, R.; Landwehrmeyer, B.; Gregory, S.; Scahill, R.I.; Langbehn, D.R.; Tabrizi, S.J. & Track HD Track On Investigators (2017), Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis, JAMA Neurology 74(11): 1352-1360.
- Moss, D.J.H.; Pardinas, A.F.; Langbehn, D.; , K. lo; Leavitt, B.R.; Roos, R.; Durr, A.; Mead, S.; Holmans, P.; Jones, L.; Tabrizi, S.J.; TRACK-HD Investigators & REGISTRY Investigators (2017), Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study, Lancet Neurology 16(9): 701-711.
- Bruggen-Rufi, M.C.H. van; Vink, A.C.; Wolterbeek, R.; Achterberg, W.P. & Roos, R.A.C. (2017), The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial, Journal of Huntington's Disease 6(1): 63-72.
- McColgan, P.; Seunarine, K.K.; Gregory, S.; Razi, A.; Papoutsi, M.; Long, J.D.; Mills, J.A.; Johnson, E.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Stout, J.C.; Scahill, R.I.; Clark, C.A.; Rees, G.; Tabrizi, S.J. & Track On HD Investigators (2017), Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease, JCI insight 2(8).
- McColgan, P.; Gregory, S.; Razi, A.; Seunarine, K.K.; Gargouri, F.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Scahill, R.I.; Clark, C.A.; Tabrizi, S.J.; Rees, G. & Track On-HD Investigators (2017), White matter predicts functional connectivity in premanifest Huntington's disease, Annals of Clinical and Translational Neurology 4(2): 106-118.
- Frost, C.; Mulick, A.; Scahill, R.I.; Owen, G.; Aylward, E.; Leavitt, B.R.; Durr, A.; Roos, R.A.C.; Borowsky, B.; Stout, J.C.; Reilmann, R.; Langbehn, D.R.; Tabrizi, S.J.; Sampaio, C. & TRACK-HD Investigators (2017), Design Optimization for Clinical Trials in Early-Stage Manifest Huntington's Disease, Movement Disorders 32(11): 1610-1619.
- Coppen, E.M. & Roos, R.A.C. (2017), Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease, Drugs 77(1): 29-46.
- Jacobs, M.; Hart, E.P. & Roos, R.A.C. (2017), Driving with a neurodegenerative disorder: an overview of the current literature, Journal of Neurology 264(8): 1678-1696.
- Brown, K.E.; Lohse, K.R.; Mayer, I.M.S.; Strigaro, G.; Desikan, M.; Casula, E.P.; Meunier, S.; Popa, T.; Lamy, J.C.; Odish, O.; Leavitt, B.R.; Durr, A.; Roos, R.A.C.; Tabrizi, S.J.; Rothwell, J.C.; Boyd, L.A. & Orth, M. (2017), The reliability of commonly used electrophysiology measures, Brain Stimulation 10(6): 1102-1111.
- Byrne, L.M.; Rodrigues, F.B.; Blennow, K.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Scahill, R.I.; Tabrizi, S.J.; Zetterberg, H.; Langbehn, D. & Wild, E.J. (2017), Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis, The Lancet Neurology 16(8): 601-609.
- Stuitje, G.; Belzen, M.J. van; Gardiner, S.L.; Roon-Mom, W.M.C. van; Boogaard, M.W.; Tabrizi, S.J.; Roos, R.A.C.; Aziz, N.A. & REGISTRY Investigators European Hu (2017), Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes, Brain 140.
- Bouwens, J.A.; Duijn, E. van; Cobbaert, C.M.; Roos, R.A.C.; Mast, R.C. van der & Giltay, E.J. (2017), Disease Stage and Plasma Levels of Cytokines in Huntington's Disease: A 2-Year Follow-Up Study, Movement Disorders 32(7): 1103-1104.
- Baake, V.; Reijntjes, R.H.A.M.; Dumas, E.M.; Thompson, J.C.; Roos, R.A.C. & REGISTRY Investigators European (2017), Cognitive decline in Huntington's disease expansion gene carriers, Cortex 95: 51-62.
- Burg, J.M.M. van der; Gardiner, S.L.; Ludolph, A.C.; Landwehrmeyer, G.B.; Roos, R.A.C. & Aziz, N.A. (2017), Body Weight Is a Robust Predictor of Clinical Progression in Huntington Disease, Annals of Neurology 82(3): 479-483.
- Gardiner, S.L.; Belzen, M.J. van; Boogaard, M.W.; Roon-Mom, W.M.C. van; Rozing, M.P.; Hemert, A.M. van; Smit, J.H.; Beekman, A.T.F.; Grootheest, G. van; Schoevers, R.A.; Voshaar, R.C.O.; Comijs, H.C.; Penninx, B.W.J.H.; Mast, R.C. van der; Roos, R.A.C. & Aziz, N.A. (2017), Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression, Translational Psychiatry 7.
- Gregory, S.; Long, J.D.; Kloppel, S.; Razi, A.; Scheller, E.; Minkova, L.; Papoutsi, M.; Mills, J.A.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Stout, J.C.; Scahill, R.I.; Langbehn, D.R.; Tabrizi, S.J. & Rees, G. (2017), Operationalizing compensation over time in neurodegenerative disease, Brain 140: 1158-1165.
- Bouwens, J.A.; Duijn, E. van; Cobbaert, C.M.; Roos, R.A.C.; Mast, R.C. van der & Giltay, E.J. (2016), Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington's disease, Journal of Huntington's Disease 5(4): 369-377.
- Cubo, E.; Ramos-Arroyo, M.A.; Martinez-Horta, S.; Martinez-Descalls, A.; Calvo, S.; Gil-Polo, C. & European HD Network (2016), Clinical manifestations of intermediate allele carriers in Huntington disease, Neurology 87(6): 571-578.
- Jacobs, M.; Hart, E.P. 't & Roos, R.A.C. (2016), Progression of motor subtypes in Huntington's disease: A six-year follow-up, Movement Disorders 31: S357-S357.
- Hubers, A.A.M.; Hamming, A.; Giltay, E.J.; Faber, M. von; Roos, R.A.C.; Mast, R.C. van der & Duijn, E. van (2016), Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies, Journal of Huntington's Disease 5(2): 185-198.
- Labuschagne, I.; Cassidy, A.M.; Scahill, R.I.; Johnson, E.B.; Rees, E.; O'Regan, A.; Queller, S.; Frost, C.; Leavitt, B.R.; Durr, A.; Roos, R.; Owen, G.; Borowsky, B.; Tabrizi, S.J.; Stout, J.C. & TRACK HD Investigators (2016), Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease, Journal of the International Neuropsychological Society 22(6): 595-608.
- Jacobs, M.; Hart, E.P.; Zwet, E.W. van; Bentivoglio, A.R.; Burgunder, J.M.; Craufurd, D.; Reilmann, R.; Saft, C.; Roos, R.A.C.; REGISTRY Investigators & European Huntington's Dis Network (2016), Progression of motor subtypes in Huntington's disease: a 6-year follow-up study, Journal of Neurology 263(10): 2080-2085.
- Orth, M.; Gregory, S.; Scahill, R.I.; Mayer, I.S.M.; Minkova, L.; Kloppel, S.; Seunarine, K.K.; Boyd, L.; Borowsky, B.; Reilmann, R.; Landwehrmeyer, G.B.; Leavitt, B.R.; Roos, R.A.C.; Durr, A.; Rees, G.; Rothwell, J.C.; Langbehn, D.; Tabrizi, S.J. & TRACK-On Investigators (2016), Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease, Human Brain Mapping 37(12): 4615-4628.
- Minkova, L.; Eickhoff, S.B.; Abdulkadir, A.; Kaller, C.P.; Peter, J.; Scheller, E.; Lahr, J.; Roos, R.A.; Durr, A.; Leavitt, B.R.; Tabrizi, S.J.; Kloppel, S. & TRACK-HD Investigators (2016), Large-Scale Brain Network Abnormalities in Huntington's Disease Revealed by Structural Covariance, Human Brain Mapping 37(1): 67-80.
- Coppen, E.M.; Grond, J. van der; Hafkemeijer, A.; Rombouts, S.A.R.B. & Roos, R.A.C. (2016), Early grey matter changes in structural covariance networks in Huntington's disease, NeuroImage: Clinical 12: 806-814.
- Oosterloo, M.; Belzen, M.J. van; Bijlsma, E.K. & Roos, R.A.C. (2016), Reply: Late onset Huntington's disease with 29 CAG repeat expansion, Journal of the Neurological Sciences 368: 343-343.
- Quinn, L.; Hamana, K.; Kelson, M.; Dawes, H.; Collett, J.; Townson, J.; Roos, R.; Plas, A.A. van der; Reilmann, R.; Frich, J.C.; Rickards, H.; Rosser, A. & Busse, M. (2016), A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease, Parkinsonism and Related Disorders 31: 46-52.
- Wiecki, T.V.; Antoniades, C.A.; Stevenson, A.; Kennard, C.; Borowsky, B.; Owen, G.; Leavitt, B.; Roos, R.; Durr, A.; Tabrizi, S.J. & Frank, M.J. (2016), A Computational Cognitive Biomarker for Early-Stage Huntington's Disease, PLoS ONE 11(2).
- Baake, V.; Hart, E.P.; Bos, R. & Roos, R.A.C. (2016), Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach, Journal of Huntington's Disease 5(1): 83-90.
- Hart E.P., Dumas E.M., Van Zwet E.W., Van der Hiele K., Jurgens C.K., Middelkoop H.A., Van Dijk J.G. & Roos R.A. (2015), Longitudinal pilot-study of sustained attention to response task and P300 manifest and pre-manifest Huntington's disease, Neuropsychology 9(1): 10-20.
- Odish, O.F.F.; Berg-Huysmans, A.A. van den; Bogaard, S.J.A. van den; Dumas, E.M.; Hart, E.P.; Rombouts, S.A.R.B.; Grond, J. van der; Roos, R.A.C. & TRACK-HD Investigator Grp (2015), Longitudinal Resting State fMRI Analysis in Healthy Controls and Premanifest Huntington's Disease Gene Carriers: A Three-Year Follow-Up Study, Human Brain Mapping 36(1): 110-119.
- Burg, J.M.M. van der; Pijl, H.; Campman, Y.J.M.; Roos, R.A.C. & Aziz, N.A. (2015), Does midlife obesity really lower dementia risk?, Lancet Diabetes and Endocrinology 3(7): 499-500.
- Valcarcel-Ocete, L.; Alkorta-Aranburu, G.; Iriondo, M.; Fullaondo, A.; Garcia-Barcina, M.; Fernandez-Garcia, J.M.; Lezcano-Garcia, E.; Losada-Domingo, J.M.; Ruiz-Ojeda, J.; Arcaya, A.A. de; Perez-Ramos, J.M.; Roos, R.A.C.; Nielsen, J.E.; Saft, C.; Zubiaga, A.M.; Aguirre, A. & European Huntington's Dis Network (2015), Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.
- Mastrokolias, A.; Ariyurek, Y.; Goeman, J.J.; Duijn, E. van; Roos, R.A.C.; Mast, R.C. van der; Ommen, G.B. van; Dunnen, J.T. den; Hoen, P.A.C. 't & Roon-Mom, W.M.C. van (2015), Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood, European Journal of Human Genetics 23(10): 1349-1356.
- Hubers, A.A.M.; Mast, R.C. van der; Pereira, A.M.; Roos, R.A.C.; Veen, L.J.; Cobbaert, C.M.; Duijn, E. van & Giltay, E.J. (2015), Hypothalamic-Pituitary-Adrenal Axis Functioning in Huntington's Disease and its Association with Depressive Symptoms and Suicidality, Journal of Neuroendocrinology 27(3): 234-244.
- (2015), Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study., NeuroImage: Clinical.
- Bouwens, J.A.; Duijn, E. van; Mast, R.C. van der; Roos, R.A.C. & Giltay, E.J. (2015), Irritability in a Prospective Cohort of Huntington's Disease Mutation Carriers\, Journal of Neuropsychiatry and Clinical Neurosciences 27(3): 206-212.
- Anastasios Mastrokolias1, Yavuz Ariyurek2, Jelle J Goeman3,4, Erik van Duijn5,6, Raymund AC Roos7, Roos C van der Mast5, GertJan B van Ommen1, Johan T den Dunnen1,2 & Peter AC 't Hoen1 and Willeke MC van Roon-Mom1 (2015), Huntington’s disease biomarker progression profile identified by transcriptome sequencing in peripheral blood, European Journal of Human Genetics 23.
- Evers, M.M.; Schut, M.H.; Pepers, B.A.; Atalar, M.; Belzen, M.J. van; Faull, R.L.M.; Roos, R.A.C. & Roon-Mom, W.M.C. van (2015), Making (anti-) sense out of huntingtin levels in Huntington disease, Molecular Neurodegeneration 10.
- Odish, O.F.F.; Leemans, A.; Reijntjes, R.H.; Bogaard, S.J.A. van den; Dumas, E.M.; Wolterbeek, R.; Tax, C.M.W.; Kuijf, H.J.; Vincken, K.L.; Grond, J. van der & Roos, R.A.C. (2015), Microstructural Brain Abnormalities in Huntington's Disease: A Two-Year Follow-Up, Human Brain Mapping 36(6): 2061-2074.
- Callaghan, J.; Stopford, C.; Arran, N.; Boisse, M.F.; Coleman, A.; Santos, R.D.; Dumas, E.M.; Hart, E.P.; Justo, D.; Owen, G.; Read, J.; Say, M.J.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Tabrizi, S.J.; Bachoud-Levi, A.C.; Bourdet, C.; Duijn, E. van & Craufurd, D. (2015), Reliability and Factor Structure of the Short Problem Behaviors Assessment for Huntington's Disease (PBA-s) in the TRACK-HD and REGISTRY studies, Journal of Neuropsychiatry and Clinical Neurosciences 27(1): 59-64.
- McColgan, P.; Seunarine, K.K.; Razi, A.; Cole, J.H.; Gregory, S.; Durr, A.; Roos, R.A.C.; Stout, J.C.; Landwehrmeyer, B.; Scahill, R.I.; Clark, C.A.; Rees, G.; Tabrizi, S.J. & Track-HD Investigators (2015), Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease, Brain 138.
- Hobbs, N.Z.; Farmer, R.E.; Rees, E.M.; Cole, J.H.; Haider, S.; Malone, I.B.; Sprengelmeyer, R.; Johnson, H.; Mueller, H.P.; Sussmuth, S.D.; Roos, R.A.C.; Durr, A.; Frost, C.; Scahill, R.I.; Landwehrmeyer, B. & Tabrizi, S.J. (2015), Short-interval observational data to inform clinical trial design in Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 86(12): 1291-1298.
- Johnson, E.B.; Rees, E.M.; Labuschagne, I.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Reilmann, R.; Johnson, H.; Hobbs, N.Z.; Langbehn, D.R.; Stout, J.C.; Tabrizi, S.J.; Scahill, R.I. & TRACK-HD Investigators (2015), The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease, Neuropsychologia 79: 138-146.
- Ritfeld, G.J.; Patel, A.; Chou, A.; Novosat, T.L.; Castillo, D.G.; Roos, R.A.C. & Oudega, M. (2015), The Role of Brain-Derived Neurotrophic Factor in Bone Marrow Stromal Cell-Mediated Spinal Cord Repair, Cell Transplantation 24(11): 2209-2220.
- Minkova, L.; Scheller, E.; Peter, J.; Abdulkadir, A.; Kaller, C.P.; Roos, R.A.; Durr, A.; Leavitt, B.R.; Tabriziw, S.J.; Kloppel, S. & TrackOn-Hd Investigators (2015), Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling, Frontiers in Human Neuroscience 9.
- Farmer, R.E.; Cassidy, A.M.; Hobbs, N.Z.; Scahill, R.; Rees, E.M.; Haider, S.; Roos, R.A.C.; Durr, A.; Leavitt, B.R.; Landwehrmeyer, G.B.; Tabrizi, S.J. & Frost, C. (2014), CAN THE DISTRIBUTION OF CAUDATE ATROPHY RATES SEEN OVER SHORT TIME INTERVALS BE PREDICTED FROM CHANGES OVER LONGER INTERVALS?, Journal of Neurology, Neurosurgery and Psychiatry 85: A36-A36.
- Johnson, E.B.; Rees, E.M.; Labuschagne, I.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Johnson, H.; Hobbs, N.Z.; Crawford, H.E.; Langbehn, D.R.; Stout, J.C.; Tabrizi, S.J.; Scahill, R.I. & TRACK-HD Investigators (2014), CORTICAL THINNING OF THE OCCIPITAL LOBE IN HUNTINGTON'S DISEASE AND ASSOCIATIONS WITH COGNITIVE PERFORMANCE, Journal of Neurology, Neurosurgery and Psychiatry 85: A36-A37.
- Herben-Dekker, M.; Oostrom, J.C.H. van; Roos, R.A.C.; Jurgens, C.K.; Witjes-Ane, M.N.W.; Kremer, H.P.H.; Leenders, K.L. & Spikman, J.M. (2014), Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease, Journal of Neurology 261(7): 1387-1397.
- Doan, N.T.; Bogaard, S.J.A. van den; Dumas, E.M.; Webb, A.G.; Buchem, M.A. van; Roos, R.A.C.; Grond, J. van der; Reiber, J.H.C. & Milles, J. (2014), Texture analysis of ultrahigh field T-2*-weighted MR images of the brain: Application to Huntington's disease, Journal of Magnetic Resonance Imaging 39(3): 633-640.
- Ritfeld, G.J.; Rauck, B.M.; Novosat, T.L.; Park, D.; Patel, P.; Roos, R.A.C.; Wang, Y.D. & Oudega, M. (2014), The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair, Biomaterials 35(6): 1924-1931.
- Heemskerk, A.W.; Verbist, B.M.; Marinus, J.; Heijnen, B.; Sjogren, E.V. & Roos, R.A.C. (2014), The Huntington's Disease Dysphagia Scale, Movement Disorders 29(10): 1312-1316.
- Sprengelmeyer, R.; Orth, M.; Muller, H.P.; Wolf, R.C.; Gron, G.; Depping, M.S.; Kassubek, J.; Justo, D.; Rees, E.M.; Haider, S.; Cole, J.H.; Hobbs, N.Z.; Roos, R.A.C.; Durr, A.; Tabrizi, S.J.; Sussmuth, S.D. & Landwehrmeyer, G.B. (2014), The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study, Psychological Medicine 44(9): 1867-1878.
- Gregory, S.; Scahill, R.I.; Stopford, C.; Orth, M.; Durr, A.; Leavitt, B.; Roos, R.A.C.; Langbehn, D.R.; Johnson, H.; Rees, G.; Tabrizi, S.J.; Craufurd, D. & TRACK-HD Investigators (2014), DIFFUSION TENSOR IMAGING AND NEUROPSYCHIATRIC DISTURBANCE IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 85: A41-A42.
- Odish, O.; Leemans, A.; Reijntjes, R.; Bogaard, S. van den; Dumas, E.; Wolterbeek, R.; Tax, C.; Kuijf, H.; Vincken, K.; Grond, J. van der & Roos, R.A.C. (2014), DIFFUSION TENSOR IMAGING IN HD: A TWO YEAR FOLLOW-UP - RESULTS FROM THE TRACK-HD STUDY, Journal of Neurology, Neurosurgery and Psychiatry 85: A42-A42.
- Mueller, H.P.; Kassubek, J.; Gron, G.; Sprengelmeyer, R.; Hobbs, N.Z.; Roos, R.A.C.; Duerr, A.; Tabrizi, S.J.; Sussmuth, S.D.; Orth, M. & Landwehrmeyer, G.B. (2014), DIFFUSION TENSOR IMAGING IN HUNTINGTON'S DISEASE: IMPACT OF THE CONTROL FOR CORRUPTED DATA IN COMPARISONS AT THE GROUP LEVEL, Journal of Neurology, Neurosurgery and Psychiatry 85: A43-A43.
- Booij, S.J.; Tibben, A.; Engberts, D.P.; Marinus, J. & Roos, R.A.C. (2014), Thinking about the end of life: a common issue for patients with Huntington's disease, Journal of Neurology 261(11): 2184-2191.
- Duijn, E. van; Reedeker, N.; Giltay, E.J.; Eindhoven, D.; Roos, R.A.C. & Mast, R.C. van der (2014), Course of Irritability, Depression and Apathy in Huntington's Disease in Relation to Motor Symptoms during a Two-Year Follow-Up Period, Neurodegenerative Diseases 13(1): 9-16.
- Hubers, A.A.M.; Mast, R.C. van der; Pereira, A.M.; Roos, R.A.C.; Veen, L.J.; Cobbaert, C.M.; Duijn, E. van & Giltay, E.J. (2014), HYPOTHALAMIC-PITUITARY-ADRENAL AXIS ACTIVITY IN HUNTINGTON'S DISEASE AND ITS ASSOCIATION WITH DEPRESSIVE SYMPTOMS AND SUICIDALITY, Journal of Neurology, Neurosurgery and Psychiatry 85: A33-A33.
- Oosterloo, M.; Belzen, M. van; Bijlsma, E. & Roos, R.A.C. (2014), IS THERE CONVINCING EVIDENCE THAT INTERMEDIATE REPEATS IN THE HTT GENE CAUSE HUNTINGTON'S DISEASE?, Journal of Neurology, Neurosurgery and Psychiatry 85: A82-A82.
- Rij, M.C. van; Gans, P.A.M.D.; Belzen, M.J. van; Roos, R.A.C.; Geraedts, J.P.M.; Rademaeker, M. de; Bijlsma, E.K. & Die-Smulders, C.E.M. de (2014), The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008), Clinical Genetics 85(1): 87-95.
- Hobbs, N.Z.; Farmer, R.E.; Rees, E.M.; Cole, J.H.; Haider, S.; Malone, I.B.; Sprengelmeyer, R.; Johnson, H.; Mueller, H.P.; Sussmuth, S.D.; Roos, R.A.C.; Durr, A.; Frost, C.; Scahill, R.I.; Landwehrmeyer, G.B. & Tabrizi, S.J. (2014), 6-, 9-AND 15-MONTH CHANGE IN CORTICAL THICKNESS AND REGION-OF-INTEREST VOLUME AND DIFFUSION METRICS IN HUNTINGTON'S DISEASE: INFORMING TRIAL DESIGN, Journal of Neurology, Neurosurgery and Psychiatry 85: A37-A37.
- Crawford, H.E.; Gregory, S.; Hobbs, N.Z.; Johnson, H.; Cole, J.H.; Rees, E.M.; Malone, I.B.; Sprengelmeyer, R.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Langbehn, D.R.; Landwehrmeyer, G.B.; Tabrizi, S.J.; Scahill, R.I.; TRACK-HD & PADDINGTON Investigators (2014), ASSOCIATION BETWEEN BRAIN VOLUME AND WHITE MATTER MICROSTRUCTURE IN HEALTHY CONTROLS, Journal of Neurology, Neurosurgery and Psychiatry 85: A39-A40.
- Bouwens, J.; Mast, R. van der; Duijn, E. van; Cobbaert, C.; Roos, R.A.C. & Giltay, E.J. (2014), ASSOCIATIONS BETWEEN DISEASE STAGE AND LEVELS OF CYTOKINES IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 85: A32-A32.
- Bruggen-Rufi, M. van; Roos, R.A.C.; Achterberg, W. & Vink, A. (2014), CAN MUSIC THERAPY IMPROVE THE QUALITY OF LIFE IN HUNTINGTON'S DISEASE?, Journal of Neurology, Neurosurgery and Psychiatry 85: A68-A69.
- Wokke, B.H.; Bergen, J.C. van den; Reijnierse, M.; Rijswijk, C.S.; Kan, H.E. & Verschuuren, J.J. (2014), BMD patients show relative sparing of hip flexion on muscle testing and MRI, Neuromuscular Disorders 24(9-10): 795-795.
- Bergen, J.C. van den; Westrum, S.M.S. van; Dekker, L.; Kooi, A.J. van der; Visser, M. de; Wokke, B.H.A.; Straathof, C.S.; Hulsker, M.A.; Aartsma-Rus, A.; Verschuuren, J.J. & Ginjaar, H.B. (2014), Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy, Journal of Neurology, Neurosurgery and Psychiatry 85(1): 92-98.
- Bergen, J.C. van den; Wokke, B.H.A.; Damme, P. van; Kooi, A.J. van der; Bleecker, J. de; Jonghe, P. de & Verschuuren, J.J. (2014), Development of a disease severity scale for Becker muscular dystrophy, Neuromuscular Disorders 24(9-10): 795-795.
- Bergen, J.C. van den; Wokke, B.H.; Janson, A.A.; Duinen, S.G. van; Hulsker, M.A.; Ginjaar, H.B.; Deutekom, J.C. van; Aartsma-Rus, A.; Kan, H.E. & Verschuuren, J.J. (2014), Dystrophin levels and clinical severity in Becker muscular dystrophy patients, Journal of Neurology, Neurosurgery and Psychiatry 85(7): 747-753.
- Wokke, B.H.; Bergen, J.C. van den; Hooijmans, M.H.; Verschuuren, J.J.; Niks, E.H. & Kan, H.E. (2014), Increase in T2 relaxation times in skeletal muscle of Duchenne but not Becker muscular dystrophy patients, Neuromuscular Disorders 24(9-10): 837-838.
- Hooijmans, M.T.; Wokke, B.H.A.; Goemans, N.; Campion, G.; Verschuuren, J.J.G.; Niks, E.H. & Kan, H.E. (2014), Longitudinal quantitative muscle MRI in 5 Duchenne boys treated with exon 51 skipping - A pilot study, Neuromuscular Disorders 24(9-10): 852-852.
- Bladen, C.L.; Thompson, R.; Jackson, J.M.; Garland, C.; Wegel, C.; Ambrosini, A.; Pisano, P.; Walter, M.C.; Schreiber, O.; Lusakowska, A.; Jedrzejowska, M.; Kostera-Pruszczyk, A.; Pol, L. van der; Wadman, R.I.; Gredal, O.; Karaduman, A.; Topaloglu, H.; Yilmaz, O.; Matyushenko, V.; Rasic, V.M.; Kosac, A.; Karcagi, V.; Garami, M.; Herczegfalvi, A.; Monges, S.; Moresco, A.; Chertkoff, L.; Chamova, T.; Guergueltcheva, V.; Butoianu, N.; Craiu, D.; Korngut, L.; Campbell, C.; Haberlova, J.; Strenkova, J.; Alejandro, M.; Jimenez, A.; Ortiz, G.G.; Enriquez, G.V.G.; Rodrigues, M.; Roxburgh, R.; Dawkins, H.; Youngs, L.; Lahdetie, J.; Angelkova, N.; Saugier-Veber, P.; Cuisset, J.M.; Bloetzer, C.; Jeannet, P.Y.; Klein, A.; Nascimento, A.; Tizzano, E.; Salgado, D.; Mercuri, E.; Sejersen, T.; Kirschner, J.; Rafferty, K.; Straub, V.; Bushby, K.; Verschuuren, J.; Beroud, C. & Lochmuller, H. (2014), Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe, Journal of Neurology 261(1): 152-163.
- Doorenweerd, N.; Straathof, C.S.M.; Dumas, E.M.; Spitali, P.; Ginjaar, H.B.; Wokke, B.H.; Schrans, D.G.M.; Bergen, J.C. van den; Zwet, E.W. van; Webb, A.; Buchem, M.A. van; Verschuuren, J.J.G.; Hendriksen, J.G.M.; Niks, E.H. & Kan, H.E. (2014), MRI detects Dp140 dystrophin isoform dependent brain changes in boys with DMD, Neuromuscular Disorders 24(9-10): 838-838.
- Wokke, B.H.; Hooijmans, M.T.; Bergen, J.C. van den; Webb, A.G.; Verschuuren, J.J. & Kan, H.E. (2014), Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy, NMR in Biomedicine 27(11): 1371-1377.
- Huijbers, M.G.; Lipka, A.F.; Plomp, J.J.; Niks, E.H.; Maarel, S.M. van der & Verschuuren, J.J. (2014), Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis, Journal of Internal Medicine 275(1): 12-26.
- Wokke, B.H.; Bergen, J.C. van den; Versluis, M.J.; Niks, E.H.; Milles, J.; Webb, A.G.; Zwet, E.W. van; Aartsma-Rus, A.; Verschuuren, J.J. & Kan, H.E. (2014), Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy, Neuromuscular Disorders 24(5): 409-416.
- Doorenweerd, N.; Dumas, E.M.; Ghariq, E.; Schmid, S.; Straathof, C.S.M.; Spitali, P.; Ginjaar, H.B.; Wokke, B.H.; Schrans, D.G.M.; Bergen, J.C. van den; Zwet, E.W. van; Webb, A.; Buchem, M.A. van; Osch, M.J.P. van; Verschuuren, J.J.G.; Hendriksen, J.G.M.; Niks, E.H. & Kan, H.E. (2014), Reduced cerebral blood flow in boys with Duchenne muscular dystrophy, Neuromuscular Disorders 24(9-10): 838-839.
- Straathof, C.S.M.; Heusden, D. van; Ippel, P.F.; Post, J.G.; Voermans, N.C.; Visser, M. de; Brusse, E.; Bergen, J.C. van den; Kooi, A.J. van der; Verschuuren, J.J.G. & Ginjaar, H.B. (2014), Refinement of diagnosis of Becker muscular dystrophy: Results of re-analysis of DNA samples, Neuromuscular Disorders 24(9-10): 794-794.
- Kempen, J.C.E.; Harlaar, J.; Kooi, A.J. van der; Groot, I.J.M. de; Bergen, J.C. van den; Niks, E.H.; Verschuuren, J.J.G.M. & Brehm, M.A. (2014), Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy, Neuromuscular Disorders 24(3): 216-221.
- Veldhuizen, O.; Campion, G.; Morgan, A.; Aygun, H.; Wojczewski, S.; Voit, T.; Carlier, P.; Verschuuren, J.; Aartsma-Rus, A. & Straub, V. (2014), SCOPE-DMD, an EU FP7 funded consortium for skipping trail across Europe in Duchenne muscular dystrophy, Neuromuscular Disorders 24(9-10): 830-830.
- Straathof, C.S.M.; Doorenweerd, N.; Wokke, B.H.A.; Dumas, E.M.; Bergen, J.C. van den; Buchem, M.A. van; Hendriksen, J.G.M.; Verschuuren, J.J.G.M. & Kan, H.E. (2014), Temporalis Muscle Hypertrophy and Reduced Skull Eccentricity in Duchenne Muscular Dystrophy, Journal of Child Neurology 29(10): 1344-1348.
- Lourbakos, A.; Hiller, M.; Kozaczynska, K.; Baptiste, R.J.; Reza, M.; Niks, E.; Koeks, Z.; Klerk, D. de; Wolterbeek, R.; Campion, G.; Nadarajah, V.D.; Szigyarto, C.A.; Calissano, M.; Muntoni, F.; Lochmuller, H.; Verschuuren, J.J.G.M.; Goemans, N.; Tulinius, M.; Kimpe, S. de; Aartsma-Rus, A.; Hoen, P.A.C. 't & Spitali, P. (2014), MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen, Human Gene Therapy 25(11): A27-A28.
- Bouwens, J.A.; Hubers, A.A.M.; Duijn, E. van; Cobbaert, C.M.; Roos, R.A.C.; Mast, R.C. van der & Giltay, E.J. (2014), Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease, European Neuropsychopharmacology 24(8).
- Evers, M.; Schut, M.; Pepers, B.; Atalar, M.; Belzen, M. van; Faull, R.; Roos, R.A.C. & Roon-Mom, W. van (2014), MAKING (ANTI-) SENSE OUT OF HUNTINGTIN LEVELS IN HUNTINGTON DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 85: A10-A10.
- Hart, E.P.; Dumas, E.M.; Schoonderbeek, A.; Wolthuis, S.C.; Zwet, E.W. van & Roos, R.A.C. (2014), Motor Dysfunction Influence on Executive Functioning in Manifest and Premanifest Huntington's Disease, Movement Disorders 29(3): 320-326.
- Gregory, S.; Scahill, R.I.; Durr, A.; Leavitt, B.; Roos, R.A.C.; Johnson, H.; Langbehn, D.R.; Rees, G.; Tabrizi, S.J. & Track-HD Investigators (2014), STRUCTURAL CONNECTIVITY IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 85: A41-A41.
- Hubers, A.A.M.; Hamming, A.; Giltay, E.J.; Faber, M. von; Roos, R.A.C.; Mast, R.C. van der & Duijn, E. van (2014), SUICIDALITY IN HUNTINGTON'S DISEASE: A QUALITATIVE STUDY ON COPING STRATEGIES AND TREATMENT OPTIONS, Journal of Neurology, Neurosurgery and Psychiatry 85: A78-A79.
- Bouwens, J.A.; Hubers, A.A.M.; Duijn, E. van; Cobbaert, C.M.; Roos, R.A.C.; Mast, R.C. van der & Giltay, E.J. (2014), Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease, European Neuropsychopharmacology 24(8): 1248-1256.
- Jankovic, J. & Roos, R.A.C. (2014), Chorea Associated With Huntington's Disease: To Treat or Not to Treat?, Movement Disorders 29(11): 1414-1418.
- Vittori, A.; Breda, C.; Repici, M.; Orth, M.; Roos, R.A.C.; Outeiro, T.F.; Giorgini, F.; Hollox, E.J. & REGISTRY Investigators European Hu (2014), Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease, Human Molecular Genetics 23(12): 3129-3137.
- Kostro, D.; Abdulkadir, A.; Durr, A.; Roos, R.; Leavitt, B.R.; Johnson, H.; Cash, D.; Tabrizi, S.J.; Scahill, R.I.; Ronneberger, O.; Kloppel, S. & Track-HD Investigators (2014), Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing, NeuroImage 98: 405-415.
- Bogaard, S.J.A. van den; Kruit, M.C.; Dumas, E.M. & Roos, R.A.C. (2014), Eye-of-the-tiger-sign in a 48 year healthy adult, Journal of the Neurological Sciences 336(1-2): 254-256.
- Wamelen, D.J. van; Aziz, N.A.; Roos, R.A.C. & Swaab, D.F. (2014), Hypothalamic Alterations in Huntington's Disease Patients: Comparison with Genetic Rodent Models, Journal of Neuroendocrinology 26(11): 761-775.
- Muller, H.P.; Kassubek, J.; Gron, G.; Sprengelmeyer, R.; Ludolph, A.C.; Kloppel, S.; Hobbs, N.Z.; Roos, R.A.C.; Duerr, A.; Tabrizi, S.J.; Orth, M.; Sussmuth, S.D. & Landwehrmeyer, G.B. (2014), Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease, BioMedical Engineering OnLine 13.
- Dumas E.M., Van den Bogaard S.J., Middelkoop H.A. & Roos R.A. (2013), A review of cognition in Huntington's disease, Frontiers in Bioscience S5: 1-18.
- Rij, M.C. van; Die-Smulders, C. de; Bijlsma, E.K.; Wert, G.M.W.R. de; Geraedts, J.P.; Roos, R.A.C. & Tibben, A. (2013), Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands.
- Wamelen, D.J. van; Aziz, N.A.; Anink, J.J.; Steenhoven, R. van; Angeloni, D.; Fraschini, F.; Jockers, R.; Roos, R.A.C. & Swaab, D.F. (2013), Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease, SLEEP 36(1): 117-125.
- Bogaard, S.J.A. van den; Dumas, E.M.; Roos, R.A.C.; Bhatia, K.P. & Schneider, S.A. (2013), The Role of Iron Imaging in Huntington's Disease, International Review of Neurobiology 110: 241-250.
- Hubers, A.A.M.; Duijn, E. van; Roos, R.A.C.; Craufurd, D.; Rickards, H.; Landwehrmeyer, G.B.; Mast, R.C. van der; Giltay, E.J. & REGISTRY Investigators European Hu (2013), Suicidal ideation in a European Huntington's disease population, Journal of Affective Disorders 151(1): 248-258.
- Scahill, R.I.; Hobbs, N.Z.; Say, M.J.; Bechtel, N.; Henley, S.M.D.; Hyare, H.; Langbehn, D.R.; Jones, R.; Leavitt, B.R.; Roos, R.A.C.; Durr, A.; Johnson, H.; Lehericy, S.; Craufurd, D.; Kennard, C.; Hicks, S.L.; Stout, J.C.; Reilmann, R.; Tabrizi, S.J. & TRACK-HD Investigators (2013), Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy, Human Brain Mapping 34(3): 519-529.
- Booij, S.J.; Engberts, D.P.; Rodig, V.; Tibben, A. & Roos, R.A.C. (2013), A plea for end-of-life discussions with patients suffering from Huntington's disease: the role of the physician, Journal of Medical Ethics 39(10): 621-624.
- Sathasivam, K.; Neueder, A.; Gipson, T.A.; Landles, C.; Benjamin, A.C.; Bondulich, M.K.; Smith, D.L.; Faull, R.L.M.; Roos, R.A.C.; Howland, D.; Detloff, P.J.; Housman, D.E. & Bates, G.P. (2013), Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease, Proceedings of the National Academy of Sciences 110(6): 2366-2370.
- Bogaard, S.J.A. van den; Dumas, E.M.; Hart, E.P.; Milles, J.; Reilmann, R.; Stout, J.C.; Craufurd, D.; Gibbard, C.R.; Tabrizi, S.J.; Buchem, M.A. van; Grond, J. van der & Roos, R.A.C. (2013), Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease: A 2-Year Follow-Up, American Journal of Neuroradiology 34(2): 317-322.
- Tabrizi, S.J.; Scahill, R.I.; Owen, G.; Durr, A.; Leavitt, B.R.; Roos, R.A.; Borowsky, B.; Landwehrmeyer, B.; Frost, C.; Johnson, H.; Craufurd, D.; Reilmann, R.; Stout, J.C.; Langbehn, D.R. & TRACK-HD Investigators (2013), Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data, Lancet Neurology 12(7): 637-649.
- Booij, S.J.; Engberts, D.P.; Tibben, A. & Roos, R.A.C. (2013), Euthanasia and physician-assisted suicide in Huntington's disease in The Netherlands., International Psychogeriatrics 25(2): 339-40.
- Hart, E.P.; Dumas, E.M.; Zwet, E.W. van; Hiele, K. van der; Jurgens, C.K.; Middelkoop, H.A.M.; Dijk, J.G. van & Roos, R.A.C. (2013), Longitudinal pilot-study of Sustained attention to response task and P300 in manifest and pre-manifest Huntington's disease.
- Wamelen, D.J. van; Aziz, N.A.; Zhao, J.; Balesar, R.; Unmehopa, U.; Roos, R.A.C. & Swaab, D.F. (2013), Decreased Hypothalamic Prohormone Convertase Expression in Huntington Disease Patients, Journal of Neuropathology and Experimental Neurology 72(12): 1126-1134.
- Youssov, K.; Dolbeau, G.; Maison, P.; Boisse, M.F.; Langavant, L.C. de; Roos, R.A.C. & Bachoud-Levi, A.C. (2013), Unified Huntington's Disease Rating Scale for Advanced Patients: Validation and Follow-Up Study, Movement Disorders 28(12): 1717-1723.
- Metzger, S.; Walter, C.; Riess, O.; Roos, R.A.C.; Nielsen, J.E.; Craufurd, D.; Nguyen, H.P. & REGISTRY Investigators European Hu (2013), The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients, PLoS ONE 8(7).
- Youssov, K.; Dolbeau, G.; Maison, P.; Boisse, M.F.; Langavant, L.C. de; Roos, R.A.C. & Bachoud-Levi, A.C. (2013), The Unified Huntington's Disease Rating Scale for Advanced Patients: Validation and Follow-Up Study, Movement Disorders 28(14): 1995-2001.
- Delmaire, C.; Dumas, E.M.; Sharman, M.A.; Bogaard, S.J.A. van den; Valabregue, R.; Jauffret, C.; Justo, D.; Reilmann, R.; Stout, J.C.; Craufurd, D.; Tabrizi, S.J.; Roos, R.A.C.; Durr, A. & Lehericy, S. (2013), The structural correlates of functional deficits in early huntington's disease, Human Brain Mapping 34(9): 2141-2153.
- Zielonka, D.; Marinus, J.; Roos, R.A.C.; Michele, G. de; Donato, S. di; Putter, H.; Marcinkowski, J.; Squitieri, F.; Bentivoglio, A.R. & Landwehrmeyer, G.B. (2013), The influence of gender on phenotype and disease progression in patients with Huntington's disease, Parkinsonism and Related Disorders 19(2): 192-197.
- Hart, E.P.; Marinus, J.; Burgunder, J.M.; Bentivoglio, A.R.; Craufurd, D.; Reilmann, R.; Saft, C.; Roos, R.A.C. & REGISTRY Investigators European (2013), Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease, Movement Disorders 28(8): 1142-1145.
- Borowsky, B.; Warner, J.; Leavitt, B.R.; Tabrizi, S.J.; Roos, R.A.C.; Durr, A.; Becker, C.; Sampaio, C.; Tobin, A.J. & Schulman, H. (2013), 8OHdG is not a biomarker for Huntington disease state or progression, Neurology 80(21): 1934-1941.
- MacLeod, R.; Tibben, A.; Frontali, M.; Evers-Kiebooms, G.; Jones, A.; Martinez-Descales, A.; Roos, R.A.; Editorial Comm & European Huntington Dis Network (2013), Recommendations for the predictive genetic test in Huntington's disease.
- Rij, M.C. van; Gans, P.A.M.D.; Aalfs, C.M.; Elting, M.; Ippel, P.F.; Maat-Kievit, J.A.; Vermeer, S.; Verschuuren-Bemelmans, C.C.; Belzen, M.J. van; Belfroid, R.D.M.; Losekoot, M.; Geraedts, J.P.M.; Roos, R.A.C.; Tibben, A.; Die-Smulders, C.E.M. de & Bijlsma, E.K. (2013), Prenatal testing for Huntington's disease in The Netherlands from 1998 to 2008.
- Kieburtz, K.; Landwehrmeyer, G.B.; Cudkowicz, M.; Dorsey, E.R.; Feigin, A.; Hunt, V.; Kayson, E.; McDermott, M.; Noonberg, S.; Seitz, W.; Soliveri, P.; Walker, F.; Burgunder, J.M.; Romero, I.; Magara, A.; Stebler, Y.; Rickards, H.; Wright, J.; Souza, J. de; Barker, R.A.; Mason, S.; Pietro, A. di; Goodman, A.; O'Keeffe, D.; Langlois, M.; Ferland, G.; Verret, L.; Chouinard, S.; Paris, S.; LePage, C.; Nemeth, A.H.; Merritt, C.; Cox, C.; Astbury, T.; Murphy, S.; Ahmed, A.; St Marie, P.; Berila, R.A.; Kubu, C.; Segro, V.; Kumar, R.; Erickson, D.; Schneiders, J.; Frucht, S.; Wasserman, P.; Moskowitz, C.; Scott, B.; Perry-Trice, P.; Wyne, S.; Soliveri, P.; Parida, D.; Redaelli, V.; Soltan, W.; Robowski, P.; Nowak, M.; Schinwelski, M.; Dziadkiewicz, A.; Andrews, T.; Ruddy, D.; Dougherty, A.; Boelmans, K.; Schmalfeld, J.; Munchau, A.; Zittel, S.; Mallonee, W.; Suter, G.; Tan, J.; Seeberger, L.; Harris, J.; Champion, J.; Wojcieszek, J.; Belden, J.; Price, K.; Hughes-Gay, M.; Sprehn, G.; Squitieri, F.; Martino, T.; Gregorio, F. de; Nicola, A. de; Elifani, F.; Rosenblatt, A.; Yoritomo, N.; Margolis, R.; Nichols, P.; Palhagen, S.E.; Hoglund, A.V.; Paucar, M.; Reza-Soltani, T.W.; Beister, A.; Raab, T.; Kieni, J.; Schrenk, C.; Banaszkiewicz, K.; Misztela, J.; Wojcik, M.; Szczygiel, E.; Golosz, M.; Rudzinska, M.; Roos, R.A.C.; Bogaard, S.J.A. van den; Bos, R.; Booij, S.J.; Hyson, C.; Megens, J.; Makaji, E.; Jenkins, M.; Hersch, S.; Maya, S.; Dresser, C.; Rosas, D.; Blindauer, K.; Schindler, C.; Hung, S.; McNees, A.A.; Tabrizi, S.; Novak, M.; Say, M.; Patel, A.; Panegyres, P.; Lewis, N.; Jukich, S.; Faull, C.; Hjermind, L.E.; Jakobsen, O.; Vogel, A.; Nielsen, T.R.; Nielsen, J.E.; Kostyk, S.; Seward, A.; Agrawal, P.; Kraakevik, J.; Hogarth, P.; Wilson, A.; Lear, J.; Kraus, P.H.; Saft, C.; Steiner, T.; Hoffmann, R.; Stamm, C.; Schollhammer, J.; Uhl, I.; Kaminski, B.; O'Donovan, K.; Quarrell, O.; Nevitt, L.; Kipps, C.; Hare, A.; Gunner, K.; Hayward, E.; Nance, M.; Hamerlinck, J.; Wielinski, C.; Yastrubetskaya, O.; Chiu, E.; Chua, P.; Mannaa, B.; Tommaso, M. de; Serpino, C.; Cormio, C.; Sciruicchio, V.; Michele, G. de; Maio, L. di; Russo, C.V.; Sacca, F.; Salvatore, E.; Tucci, T.; Wolz, M.; Klingelhofer, L.; Wolz, A.; Schmidt, S.; Storch, A.; Spruth, E.; Thiel, S.; Neumann, B.; Gelderblom, H.; Priller, J.; Sass, C.; Probst, D.; Werner, C.; Leavitt, B.R.; Coleman, A.; Raymond, L.; Wheelock, V.; Tempkin, T.; Baynes, K.; Hermanowicz, N.; Niswonger, S.; Haske-Palomino, M.; Bordelon, Y.; Gratiano, A.; Johnson, A.; Corey-Bloom, J.; Goldstein, J.; Peavy, G.; Geschwind, M.; Gooblar, J.; Barton, C.; Fernandez, H.; Rodriguez, R.; Suelter, M.; Daniels, M.; Romrell, J.; Swartz, C.; Beglinger, L.; Epping, E.; Waterman, E.; Smith, M.M.; Dubinsky, R.; Dubinsky, H.; Gray, C.; Craufurd, D.; Howard, E.; Jones, M.; Murphy, H.; Anderson, K.; Nickerson, C.; Santo, J. de; Rigaud, T.; Zappala, N.; Robottom, B.; Singer, C.; Quesada, M.; Rodriguez-Spengler, K.; Cardenache, R.H.; Reilmann, R.; Bohlen, S.; Hoelzner, E.M.; Colcher, A.; Maccarone, H.; Altin, L.; Siderowf, A.; Greenamyre, T.J.; Lucarelli, N.; Ivanco, L.; Marshall, F.; Hickey, C.; Deuel, L.; Biglan, K.; Sussmuth, S.D.; Orth, M.; Trautmann, S.; Eschenbach, C.; Samii, A.; Macaraeg, A.; Zielonka, D.; Ciesielska, A.; Marcinkowski, J.T.; Sempolowicz, J.; Karaskiewicz, H.; Walker, F.; O'Neill, C.; Haq, I.; Witkowski, G.; Antczak, J.; Rola, R.; Richter, P.; Rakowicz, M.; Jachinska, K.; Criswell, S.; Deppen, P.; Wharton, K.; Mahant, N.; McCusker, E.; Griffith, J.; Loy, C.; Stewart, L.; Fisher, D.; Holt, D.; Orme, C.; Watts, A.; Weber, J.; White, K.; Hauser, R.A.; Albin, R.; Coffey, C.; Fischer, W.; Miyasaki, J. & HORIZON Investigators (2013), A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease, JAMA Neurology 70(1): 25-33.
- Wamelen, D.J. van; Aziz, N.A.; Anink, J.J.; Roos, R.A.C. & Swaab, D.F. (2013), Neuropeptide Alterations in the Infundibular Nucleus of Huntington's Disease Patients, Journal of Neuroendocrinology 25(2): 198-205.
- Hart E.P., Dumas E.M., Reijntjes R.H., Hiele K. van der, Bogaard S.J., Middelkoop H.A.M., Roos R.A. & Van Dijk G.J. (2012), Deficient sustained attention to response task and P300 characteristics in early Huntington's disease, Journal of Neurology 259(6): 1191-1198.
- Dumas, E.M.; Bogaard, S.J.A. van den; Ruber, M.E.; Reilman, R.R.; Stout, J.C.; Craufurd, D.; Hicks, S.L.; Kennard, C.; Tabrizi, S.J.; Buchem, M.A. van; Grond, J. van der & Roos, R.A.C. (2012), Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease, Human Brain Mapping 33(1): 203-212.
- Dumas, E.M.; Versluis, M.J.; Bogaard, S.J.A. van den; Osch, M.J.P. van; Hart, E.P.; Roon-Mom, W.M.C. van; Buchem, M.A. van; Webb, A.G.; Grond, J. van der & Roos, R.A.C. (2012), Elevated brain iron is independent from atrophy in Huntington's Disease, NeuroImage 61(3): 558-564.
- A'Campo, L.E.I.; Wekking, E.M.; Spliethoff-Kamminga, N.G.A.; Stijnen, T. & Roos, R.A.C. (2012), Treatment effect modifiers for the patient education programme for Parkinson's disease., International Journal of Clinical Practice 66(1): 77-83.
- Hart, E.P.; Dumas, E.M.; Reijntjes, R.H.A.M.; Hiele, K. van der; Bogaard, S.J.A. van den; Middelkoop, H.A.M.; Roos, R.A.C. & Dijk, J.G. van (2012), Deficient sustained attention to response task and P300 characteristics in early Huntington's disease, Journal of Neurology 259(6): 1191-1198.
- Reedeker, W.; Mast, R.C. van der; Giltay, E.J.; Kooistra, T.A.D.; Roos, R.A.C. & Duijn, E. van (2012), Psychiatric Disorders in Huntington's Disease: A 2-Year Follow-up Study, Psychosomatics 53(3): 220-229.
- Hubers, M.; Duijn, E. van; Roos, R.; Mast, R. van der; Giltay, E. & European Huntington's Dis Network (2012), SUICIDALITY IN A EUROPEAN HUNTINGTON'S DISEASE POPULATION, Journal of Neurology, Neurosurgery and Psychiatry 83: A42-A43.
- Sprengelmeyer, R.; Muller, H.P.; Sussmuth, S.D.; Groen, G.; Hobbs, N.Z.; Cole, J.; Roos, R.A.C.; Durr, A.; Tabrizi, S.J. & Landwehrmeyer, G.B. (2012), THE NEUROANATOMY OF DEPRESSION: EVIDENCE FROM HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 83: A41-A42.
- Frost, C.; Jones, R.; Labuschange, I.; Say, M.; Justo, D.; Coleman, A.; Dumas, E.; Hart, E. 't; Owen, G.; Durr, A.; Leavitt, B.; Roos, R.; O'Regan, A.; Tabrizi, S.J. & Stout, J.C. (2012), THE POTENTIAL OF A COMPOSITE COGNITIVE SCORE FOR TRACKING PROGRESSION IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 83: A36-A36.
- Wamelen, D.J. van; Aziz, N.A.; Anink, J.J.; Roos, R.A.C. & Swaab, D.F. (2012), Paraventricular Nucleus Neuropeptide Expression in Huntington's Disease Patients.
- Cong, S.Y.; Pepers, B.A.; Zhou, T.T.; Kerkdijk, H.; Roos, R.A.; Ommen, G.J. van & Dorsman, J.C. (2012), Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway, Neurobiology of Disease 46(3): 673-681.
- Bogaard, S.J.A. van den; Dumas, E.M.; Milles, J.; Reilmann, R.; Stout, J.C.; Craufurd, D.; Buchem, M.A. van; Grond, J. van der & Roos, R.A.C. (2012), Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease.
- Hubers, A.A.M.; Reedeker, N.; Giltay, E.J.; Roos, R.A.C.; Duijn, E. van & Mast, R.C. van der (2012), Suicidality in Huntington's disease, Journal of Affective Disorders 136(3): 550-557.
- Ritfeld, G.J.; Tewarie, R.D.S.N.; Vajn, K.; Rahiem, S.T.; Hurtado, A.; Wendell, D.F.; Roos, R.A.C. & Oudega, M. (2012), Bone Marrow Stromal Cell-Mediated Tissue Sparing Enhances Functional Repair After Spinal Cord Contusion in Adult Rats, Cell Transplantation 21(7): 1561-1575.
- Stout, J.C.; Jones, R.; Labuschagne, I.; O'Regan, A.M.; Say, M.J.; Dumas, E.M.; Queller, S.; Justo, D.; Santos, R.D.; Coleman, A.; Hart, E.P.; Durr, A.; Leavitt, B.R.; Roos, R.A.; Langbehn, D.R.; Tabrizi, S.J. & Frost, C. (2012), Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 83(7): 687-694.
- Tabrizi, S.J.; Reilmann, R.; Roos, R.A.C.; Durr, A.; Leavitt, B.; Owen, G.; Jones, R.; Johnson, H.; Craufurd, D.; Hicks, S.L.; Kennard, C.; Landwehrmeyer, B.; Stout, J.C.; Borowsky, B.; Scahill, R.I.; Frost, C.; Langbehn, D.R. & TRACK-HD Investigators (2012), Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data, Lancet Neurology 11(1): 42-53.
- Borowsky, B.; Warner, J.; Matson, W.; Johnson, H.; Durr, A.; Roos, R.; Tabrizi, S.J.; Leavitt, B.; Becker, C.; Tobin, A. & Schulman, H. (2012), 8OHDG IS NOT A BIOMARKER FOR HUNTINGTON'S DISEASE; LESSONS FOR FUTURE BIOMARKER STUDIES, Journal of Neurology, Neurosurgery and Psychiatry 83: A25-A26.
- Mueller, H.P.; Sprengelmeyer, R.; Sussmuth, S.D.; Groen, G.; Hobbs, N.Z.; Roos, R.A.C.; Durr, A.; Schoonderbeek, A.; Hart, E. 't; Valabregue, R.; Landwehrmeyer, G.B.; Kassubek, J. & Tabrizi, S.J. (2012), A MULTICENTRE APPROACH FOR THE DETECTION OF PATTERNS OF IMPAIRMENT IN HUNTINGTON'S DISEASE BY USING DIFFUSION TENSOR IMAGING, Journal of Neurology, Neurosurgery and Psychiatry 83: A28-A29.
- Hart, E. 't; Marinus, H.; Burgunder, J.M.; Bentivoglio, A.R.; Craufurd, D.; Reilmann, R.; Saft, C.; Roos, R. & European Huntington's Dis Network (2012), BETTER GLOBAL AND COGNITIVE FUNCTIONING FOR CHOREATIC COMPARED TO HYPOKINETIC-RIGID HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 83: A2-A2.
- Crawford, H.E.; Hobbs, N.Z.; Cole, J.; Rees, E.M.; Owen, G.; Langbehn, D.R.; Frost, C.; Landwehrmeyer, B.; Reilmann, R.; Craufurd, D.; Stout, J.C.; Durr, A.; Leavitt, B.; Roos, R.A.; Tabrizi, S.J.; Scahill, R.I. & TRACK-HD Investigators (2012), CORPUS CALLOSAL ATROPHY IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 83: A27-A27.
- Duijn, E. van; Reedeker, N.; Giltay, E.J.; Roos, R.A.C. & Mast, R.C. van der (2012), COURSE OF IRRITABILITY, DEPRESSION, AND APATHY IN HUNTINGTON'S DISEASE DURING A 2-YEAR FOLLOW-UP PERIOD, Journal of Neurology, Neurosurgery and Psychiatry 83: A42-A42.
- Bouwens, J.; Hubers, M.; Mast, R. van der; Roos, R.; Duijn, E. van & Giltay, E. (2012), CROSS-SECTIONAL AND LONGITUDINAL ASSOCIATIONS BETWEEN CRP AND NEUROPSYCHIATRIC SYMPTOMS IN HD, Journal of Neurology, Neurosurgery and Psychiatry 83: A23-A23.
- Hobbs, N.Z.; Cole, J.; Farmer, R.E.; Rees, E.M.; Scahill, R.I.; Crawford, H.E.; Roos, R.A.C.; Sprengelmeyer, R.; Durr, A.; Landwehrmeyer, B.; Tabrizi, S.J. & Frost, C. (2012), EVALUATION OF MULTI-MODAL, MULTI-SITE IMAGING MEASURES IN HUNTINGTON'S DISEASE: BASELINE RESULTS FROM THE PADDINGTON STUDY, Journal of Neurology, Neurosurgery and Psychiatry 83: A26-A26.
- Reedeker, N.; Bouwens, J.; Giltay, E.; Mast, R. van der; Roos, R. & Duijn, E. van (2012), INCIDENCE AND COURSE OF IRRITABILITY IN HUNTINGTON'S DISEASE, Journal of Neurology, Neurosurgery and Psychiatry 83: A42-A42.
- Bruggen-Rufi, M. van & Roos, R. (2012), MUSIC THERAPY AS A METHOD TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH HUNTINGTON'S DISEASE: PRELIMINARY FINDINGS, Journal of Neurology, Neurosurgery and Psychiatry 83: A60-A60.
- Hicks, S.; Scahill, R.I.; Dumas, E.; Durr, A.; Blair, R.; Levitt, B.R.; Roos, R.A.C.; Tabrizi, S.J. & Kennard, C. (2012), OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY, Journal of Neurology, Neurosurgery and Psychiatry 83.
- Jurgens C.K., Van der Hiele K., Reijntjes R.H., Van de Wiel L., Witjes-Ané M.N., Van der Grond J., Roos R.A., Middelkoop H.A.M. & Van Dijk J.G. (2011), Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's disease, European Journal of Neurology 18(8): 1105-1108.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Roelfsema, F. & Roos, R.A.C. (2011), Diurnal Secretion Profiles of Growth Hormone, Thyrotrophin and Prolactin in Parkinson's Disease, Journal of Neuroendocrinology 23(6): 519-524.
- Aziz, N.A.; Belzen, M.J. van; Coops, I.D.; Belfroid, R.D.M. & Roos, R.A.C. (2011), Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease, European Journal of Medical Genetics 54(4): E413E418.
- Bogaard, S.J.A. van den; Dumas, E.M.; Teeuwisse, W.M.; Kan, H.E.; Webb, A.; Roos, R.A.C. & Grond, J. van der (2011), Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism, Journal of Neurology 258(12): 2230-2239.
- A'Campo, L.E.I.; Spliethoff-Kamminga, N.G.A. & Roos, R.A.C. (2011), An evaluation of the patient education programme for Parkinson's disease in clinical practice, International Journal of Clinical Practice 65(11): 1173-1179.
- Aziz, N.A.; Roon-Mom, W.M.C. van & Roos, R.A.C. (2011), CAG repeat size in the normal HTT allele and age of onset in Huntington's disease.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Roelfsema, F. & Roos, R.A.C. (2011), Leptin, Adiponectin, and Resistin Secretion and Diurnal Rhythmicity are Unaltered in Parkinson's Disease.
- Riffeld, G.J.; Roos, R.A.C. & Oudega, M. (2011), Stem Cells for Central Nervous System Repair and Rehabilitation, PM&R 3(6): S117-S122.
- Reedeker, N.; Bouwens, J.A.; Duijn, E. van; Giltay, E.J.; Roos, R.A.C. & Mast, R.C. van der (2011), Incidence, Course, and Predictors of Apathy in Huntington's Disease: A Two-Year Prospective Study.
- Burg, J.M.M. van der; Winqvist, A.; Aziz, N.A.; Maat-Schieman, M.L.C.; Roos, R.A.C.; Bates, G.P.; Brundin, P.; Bjorkqvist, M. & Wierup, N. (2011), Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice, Neurobiology of Disease 44(1): 1-8.
- Wamelen, D.J. van; Shan, L.; Aziz, N.A.; Anink, J.J.; Bao, A.M.; Roos, R.A.C. & Swaab, D.F. (2011), Functional Increase of Brain Histaminergic Signaling in Huntington's Disease.
- Lopez-Sendon, J.L.; Royuela, A.; Trigo, P.; Orth, M.; Lange, H.; Reilmann, R.; Keylock, J.; Rickards, H.; Piacentini, S.; Squitieri, F.; Landwehrmeyer, B.; Witjes-Ane, M.N.; Jurgens, C.K.; Roos, R.A.C.; Abraira, V.; Yebenes, J.G. de & European HD Network (2011), What is the Impact of Education on Huntington's Disease?
- Ritfeld, G.J.; Vajn, K.; Roos, R.A.C. & Oudega, M. (2011), Effect of Spinal Cord Tissue Preservation by Bone Marrow Stromal Cells on Functional Recovery After Spinal Cord Contusion in Rats: More Is Better, Cell Transplantation 20(4): 580-581.
- Heemskerk, A.W. & Roos, R.A.C. (2011), Dysphagia in Huntington's Disease: A Review, Dysphagia 26(1): 62-66.
- Tabrizi, S.J.; Scahill, R.I.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Jones, R.; Landwehrmeyer, G.B.; Fox, N.C.; Johnson, H.; Hicks, S.L.; Kennard, C.; Craufurd, D.; Frost, C.; Langbehn, D.R.; Reilmann, R.; Stout, J.C. & TRACK-HD Investigators (2011), Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis, Lancet Neurology 10(1): 31-42.
- Aziz, N.A.; Pijl, H. & Roos, R.A.C. (2011), Weight Loss and Exercise in Obese Older Adults, New England Journal of Medicine 364(25): 2467-2467.
- Luyendijk, J.; Steens, S.C.A.; Ouwendijk, W.J.N.; Steup-Beekman, G.M.; Bollen, E.L.E.M.; Grond, J. van der; Huizinga, T.W.J.; Emmer, B.J. & Buchem, M.A. van (2011), Neuropsychiatric Systemic Lupus Erythematosus Lessons Learned From Magnetic Resonance Imaging, Arthritis and Rheumatism 63(3): 722-732.
- Bogaard, S.J.A. van den; Dumas, E.M.; Acharya, T.P.; Johnson, H.; Langbehn, D.R.; Scahill, R.I.; Tabrizi, S.J.; Buchem, M.A. van; Grond, J. van der; Roos, R.A.C. & TRACK-HD Investigator Grp (2011), Early atrophy of pallidum and accumbens nucleus in Huntington's disease, Journal of Neurology 258(3): 412-420.
- Jurgens, C.K.; Hiele, K. van der; Reijntjes, R.H.A.M.; Wiel, L. van de; Witjes-Ane, M.N.W.; Grond, J. van der; Roos, R.A.C.; Middelkoop, H.A.M. & Dijk, J.G. van (2011), Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's disease, European Journal of Neurology 18(8): 1105-1108.
- Bogaard, S.J.A. van den; Dumas, E.M.; Ferrarini, L.; Milles, J.; Buchem, M.A. van; Grond, J. van der & Roos, R.A.C. (2011), Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy - Results from the TRACK-HD study, Journal of the Neurological Sciences 307(1-2): 60-68.
- A'Campo, L.E.I.; Wekking, E.M.; Spliethoff-Kamminga, N.G.A.; Cessie, S. le & Roos, R.A.C. (2010), The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers.
- Munneke, M.; Nijkrake, M.J.; Keus, S.H.J.; Kwakkel, G.; Berendse, H.W.; Roos, R.A.C.; Borm, G.F.; Adang, E.M.; Overeem, S.; Bloem, B.R. & ParkinsonNet Trial Study Grp (2010), Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial, Lancet Neurology 9(1): 46-54.
- Oosterveer, D.M.; Overweg-Plandsoen, W.C.T. & Roos, R.A.C. (2010), Sydenham's Chorea: A Practical Overview of the Current Literature, Pediatric Neurology 43(1): 1-6.
- A'Campo, L.E.I.; Spliethoff-Kamminga, N.G.A.; Macht, M.; Roos, R. & EduPark Consortium (2010), Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries, Quality of Life Research 19(1): 55-64.
- Aziz, N.A.; Anguelova, G.V.; Marinus, J.; Lammers, G.J. & Roos, R.A.C. (2010), Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease, Parkinsonism and Related Disorders 16(5): 345-350.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Schroder-van der Elst, J.P.; Bent, C. van der; Roelfsema, F. & Roos, R.A.C. (2010), Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease, European Journal of Neurology 17(2): 280-288.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Graaf, W.M. van der; Roelfsema, F. & Roos, R.A.C. (2010), Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients, Clinical Endocrinology 73(2): 206-211.
- Duijn, E. van; Selis, M.A.; Giltay, E.J.; Zitman, F.G.; Roos, R.A.C.; Pelt, H. van & Mast, R.C. van der (2010), Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls, Brain Research Bulletin 83(5): 232-237.
- Duijn, E. van; Reedeker, N.; Giltay, E.J.; Roos, R.A.C. & Mast, R.C. van der (2010), Correlates of Apathy in Huntington's Disease.
- Reedeker, N.; Mast, R.C. van der; Giltay, E.J.; Duijn, E. van & Roos, R.A.C. (2010), Hypokinesia in Huntington's Disease Co-occurs with Cognitive and Global Dysfunctioning, Movement Disorders 25(11): 1612-1618.
- Jurgens, C.K.; Bos, R.; Luyendijk, J.; Witjes-Ane, M.N.W.; Grond, J. van der; Middelkoop, H.A.M. & Roos, R.A.C. (2010), Magnetization transfer imaging in 'premanifest' Huntington's disease, Journal of Neurology 257(3): 426-432.
- Aziz, N.A.; Anguelova, G.V.; Marinus, J.; Dijk, J.G. van & Roos, R.A.C. (2010), Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease, European Journal of Neurology 17(8): 1068-1074.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Roelfsema, F. & Roos, R.A.C. (2010), Altered thyrotropic and lactotropic axes regulation in Huntington's disease, Clinical Endocrinology 73(4): 540-545.
- Euser, S.M.; Sattar, N.; Witteman, J.C.M.; Bollen, E.L.E.M.; Sijbrands, E.J.G.; Hofman, A.; Perry, I.J.; Breteler, M.M.B.; Westendorp, R.G.J. & PROSPER Rotterdam Study (2010), A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People Results From PROSPER and the Rotterdam Study, Diabetes 59(7): 1601-1607.
- Vries, B. de; Steup-Beekman, G.M.; Haan, J.; Bollen, E.L.; Luyendijk, J.; Frants, R.R.; Terwindt, G.M.; Buchem, M.A. van; Huizinga, T.W.J.; Maagdenberg, A.M.J.M. van den & Ferrari, M.D. (2010), TREX1 gene variant in neuropsychiatric systemic lupus erythematosus, Annals of the Rheumatic Diseases 69(10): 1886-1887.
- Bechtel, N.; Scahill, R.I.; Rosas, H.D.; Acharya, T.; Bogaard, S.J.A. van den; Jauffret, C.; Say, M.J.; Sturrock, A.; Johnson, H.; Onorato, C.E.; Salat, D.H.; Durr, A.; Leavitt, B.R.; Roos, R.A.C.; Landwehrmeyer, G.B.; Langbehn, D.R.; Stout, J.C.; Tabrizi, S.J. & Reilmann, R. (2010), Tapping linked to function and structure in premanifest and symptomatic Huntington disease, Neurology 75(24): 2150-2160.
- Ritfeld, G.J.; Tewarie, R.D.N.; Rahiem, S.T.; Hurtado, A.; Roos, R.A.; Grotenhuis, A. & Oudega, M. (2010), Reducing macrophages to improve bone marrow stromal cell survival in the contused spinal cord, NeuroReport 21(3): 221-226.
- Pril, R. de; Hobo, B.; Tijn, P. van; Roos, R.A.C.; Leeuwen, F.W. van & Fischer, D.F. (2010), Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model, Molecular and Cellular Neuroscience 43(3): 281-286.
- Aziz, N.A.; Pijl, H.; Frolich, M.; Snel, M.; Streefland, T.C.M.; Roelfsema, F. & Roos, R.A.C. (2010), Systemic energy homeostasis in Huntington's disease patients, Journal of Neurology, Neurosurgery and Psychiatry 81(11): 1233-1237.
- Duijn, E. van; Giltay, E.J.; Zitman, F.G.; Roos, R.A.C. & Mast, R.C. van der (2010), Measurement of Psychopathology in Huntington's Disease The Critical Role of Caregivers, Journal of Nervous and Mental Disease 198(5): 329-333.
- Aziz NA, Roelfsema F, Frolich M, Roos RAC & Pijl H (2009), A strategy for finding the optimal deconvolution estimates for hormone secretory kinetics using AutoDecon, Analytical Biochemistry 391(1): 69-71.
- Aziz, N.A.; Jurgens, C.K.; Landwehrmeyer, G.B.; Roon-Mom, W.M.C. van; Ommen, G.J.B. van; Stijnen, T.; Roos, R.A.C.; Orth, M.; Handley, O.J.; Schwenke, C.; Ho, A.; Wild, E.J.; Tabrizi, S.J.; Landwehrmeyer, G.B.; Bachoud-Levi, A.C.; Bentivoglio, A.R.; Biunno, I.; Bonelli, R.; Burgunder, J.M.; Dunnett, S.B.; Ferreira, J.J.; Handley, O.J.; Heiberg, A.; Illman, T.; Levey, J.; Nielsen, J.E.; Paivarinta, M.; Roos, R.A.C.; Sebastian, A.R.; Tabrizi, S.J.; Vandenberghe, W.; Verellen-Dumoulin, C.; Zaremba, J.; Uhrova, T.; Wahlstrom, J.; Wallner, M.; Barth, K.; Garde, M.B.; Bos, R.; Ecker, D.; Handley, O.J.; Heinonen, N.; Held, C.; Laura, M.; Descals, A.M.; Mestre, T.; Monza, D.; Naji, J.; Padieu, H.; Koivisto, S.P.; Rialland, A.; Sasinkova, P.; Cubillo, P.T.; Walsem, M. van; Witjes-Ane, M.N.; Zielonka, D.; Bonelli, R.M.; Herranhof, B.; Hodl, A.; Koppitz, M.; Magnet, M.; Otti, D.; Painold, A.; Reisinger, K.; Flamez, A.; Morez, V.; Raedt, S. de; Ribai, P.; Verellen-Dumoulin, C.; Vandenberghe, W.; Reijen, D. van; Hasholt, L.; Hjermind, L.E.; Jakobsen, O.; Norremolle, A.; Sorensen, S.A.; Stokholm, J.; Peippo, M.; Sipponen, M.; Hiivola, H.; Martikainen, K.; Tuuha, K.; Kosinski, C.M.; Probst, D.; Sass, C.; Schiefer, J.; Schlangen, C.; Werner, C.J.; Priller, J.; Pruss, H.; Andrich, J.; Hoffmann, R.; Kraus, P.; Prehn, C.; Saft, C.; Salmen, S.; Strassburger, K.; Lange, H.; Hunger, U.; Lohle, M.; Schmidt, S.; Storch, A.; Wolz, A.; Wolz, M.; Lammbeck, J.; Zucker, B.; Hidding, U.; Munchau, A.; Orth, M.; Stubbe, L.; Heinicke, W.; Longinus, B.; Moller, J.C.; Rissling, I.; Peinemann, A.; Stadtler, M.; Weindl, A.; Bohlen, S.; Lange, H.; Reilmann, R.; Beister, A.; Dose, M.; Leythaeuser, G.; Marquard, R.; Schrenk, C.; Schuierer, M.; Wiedemann, A.; Ecker, D.; Landwehrmeyer, B.; Lezius, F.; Trautmann, S.; Bertini, E.; Mechi, C.; Paganini, M.; Piacentini, S.; Romoli, M.; Sorbi, S.; Abbruzzese, G.; Ferrandes, M.B.D.G.; Mandes, P.; Marchese, R.; Albanese, A.; Donato, S. di; Mariotti, C.; Soliveri, P.; Carlo, R.; Luigi, D.M.; Michele, G. de; Rinaldi, C.; Salvatore, E.; Tucci, T.; Ciarmiello, A.; Martino, T.; Simonelli, M.; Squitieri, F.; Bentivoglio, A.R.; Fasano, A.; Frontali, M.; Guidubaldi, A.; Ialongo, T.; Jacopini, G.; Loria, G.; Piano, C.; Romano, S.; Soleti, F.; Spadaro, M.; Zinzi, P.; Heiberg, A.; Walsem, M.R. van; Bjorgo, K.; Fannemel, M.; Gorvell, P.; Retterstol, L.; Bjornevoll, I.; Sando, S.B.; Sitek, E.J.; Slawek, J.; Soltan, W.; Rudzinska, M.; Szczudlik, A.; Wojcik, M.; Bryl, A.; Ciesielska, A.; Klimberg, A.; Kozubski, W.; Marcinkowski, J.; Sempolowicz, P.J.; Zielonka, D.; Janik, P.; Kalbarczyk, A.; Kwiecinski, H.; Jamrozik, Z.; Antczak, J.; Rakowicz, M.; Richter, P.; Ryglewicz, D.; Zaremba, J.; Zdzienicka, E.; Costa, C.; Coelho, M.; Ferreira, J.J.; Mestre, T.; Rosa, M.M.; Valadas, A.; Gago, M.; Garrett, C.; Guerra, M.R.; Bas, J.; Calopa, M.; Barbera, M.A.; Badenes, D.; Casas, L.; Arroyo, S.E.; Vara, J.H.; Krupinski, J.; Lopez, J.; Obdulia, M.; Ferrer, P.Q.; Sebastian, A.R.; Contreras, S.R.; Carruesco, G.T.; Cubo, E.; Mariscal, N.; Sanchez, J.; Barrero, F.J.; Morales, B.; Moreno, J.L.L.S.; Garcia, R.G.R.; Quiroga, P.P.; Villanueva, C.; Ruiz-Espiga, P.J.G.; Martinez, A.; Artiga, M.J.S.; Sanchez, V.; Bascunana, M.; Fatas, M.; Ribas, G.G.; Yebenes, J.G. de; Moreno, J.L.L.; Schwarz, C.; Cubillo, P.T.; Arques, P.N.; Gorospe, A.; Legarda, I.; Rodriguez, M.J.T.; Gaston, I.; Ramos-Arroyo, M.A.; Val, J.L. del; Martinez, L.; Burgunder, J.M.; Romero, I.; Schupbach, M.; Zaugg, S.W.; Hout, M.S.E. van; Vugt, J.P.P. van; Weert, A.M. de; Bolwijn, J.J.W.; Dekker, M.; Leenders, K.L.; Oostrom, J.C.H. van; Bos, R.; Dumas, E.; Jurgens, C.K.; Roos, R.A.C.; Witjes-Ane, M.N.; Matheson, K.; Rae, D.; Simpson, S.; Summers, F.; Ure, A.; Curtis, A.; Keylock, J.; Rickards, H.; Wright, J.; Barker, R.A.; Fisher, K.; Goodman, A.O.G.; Hill, S.; Kershaw, A.; Mason, S.; Paterson, N.; Raymond, L.; Bisson, J.; Busse, M. & Ellison-Rose, L (2009), Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease, Neurology 73(16): 1280-1285.
- Aziz NA, Pijl H, Frolich M, van der Graaf AWM, Roelfsema F & Roos RAC (2009), Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington's Disease, Journal of Clinical Endocrinology and Metabolism 94(4): 1223-1228.
- Aziz NA & Roos RAC (2009), Huntington CAG Repeat Size Does Not Modify Onset Age in Familial Parkinson's Disease: The GenePD Study, Movement Disorders 24(8): 1253-1253.
- Nijssen PCG, Brekelmans GJF & Roos RAC (2009), Electroencephalography in autosomal dominant adult neuronal ceroid lipofuscinosis, Clinical Neurophysiology 120(10): 1782-1786.
- Aziz NA, Pijl H, Frolich M, Schroder-van der Elst JP, van der Bent C, Roelfsema F & Roos RAC (2009), Delayed onset of the diurnal melatonin rise in patients with Huntington's disease, Journal of Neurology 256(12): 1961-1965.
- van Oostrom J, Dekker M, Willemsen ATM, de Jong BM, Roos RAC & Leenders KL (2009), Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease, European Journal of Neurology 16(2): 226-231.
- Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B & Stout JC (2009), Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, Lancet Neurology 8(9): 791-801.
- van den Bergen JC, Ginjaar HB, van der Kooi AJ, Niks EH, Straathof CSM, Aartsma-Rus AM, van Ommen GJ & Verschuuren JJG (2009), Clinical and genetic aspects of Becker muscular dystrophy in the Netherlands, Journal of the Neurological Sciences 285: S124S124.
- Titulaer MJ, Phernambucq M, Zhernakova A, van der Slik A, Wirtz PW, Niks EH, Martinez-Martinez P, Losen M, Bakker E, Wijmenga C, Koeleman BPC, De Baets MH & Verschuuren JJG (2009), Genetic factors in myasthenia gravis and Lambert-Eaton myasthenic syndrome, Journal of the Neurological Sciences 285: S152S152.
- van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RAC & van der Mast RC (2008), Cross-Sectional Study on Prevalences of Psychiatric Disorders in Mutation Carriers of Huntington's Disease Compared With Mutation-Negative First-Degree Relatives, Journal of Clinical Psychiatry 69(11).
- Dumas E, van den Bogaard S, Jurgens C, Witjes-Ane N, Teeuwisse W, van Buchem M, van der Grond J & Roos R (2008), 7T magnetic resonance spectroscopy in Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab D & Roos R (2008), Hypocretin and melanin-concentrating hormone in patients with Huntington disease.
- Aziz NA, Pijl H, Froelich M, Van der Graaf M, Roelfsema F & Roos RAC (2008), Increased activity of the hypothalamic-adrenal axis in early-stage Huntington's disease patients, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Aziz NA, van der Marck MA, Pijl H, Rikkert MGMO, Bloem BR & Roos RAC (2008), Weight loss in neurodegenerative disorders, Journal of Neurology 255(12): 1872-1880.
- Timman R, Claus H, Roos R & Tibben A (2008), The behaviour observation scale Huntington's disease: Longitudinal validation, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Dekker M, van Oostrom J, Jurgens C, Witjes-Ane MN, Spikman J, Roos R & Leenders N (2008), Cognition in relation to metabolic changes in the brain of preclinical mutation carriers of Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Jurgens CK, van de Wiel L, van Es ACGM, Grimbergen YM, Witjes-Ane MNW, van der Grond J, Middelkoop HAM & Roos RAC (2008), Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease, Journal of Neurology 255(11): 1785-1791.
- van Duijn E, Selis M, Giltay E, Zitman F, Roos R, van Pelt H & van der Mast R (2008), Dysregulation of the hypothalamic-pituitary-adrenal axis in Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Kingma EM, van Duijn E, Timman R, van der Mast RC & Roos RAC (2008), Behavioural problems in Huntington's disease using the problem behaviours assessment, General Hospital Psychiatry 30(2).
- Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T & Roos RAC (2008), Weight loss in Huntington disease increases with higher CAG repeat number, Neurology 71(19).
- van Vugt JPP, Wolkorte R, Bos R, Jurgens CK, Lange HW, Reilmann R & Roos RAC (2008), The Ten Euro Neurotest: A simple, quantitative test of dexterity that is useful in the follow-up of presymptomatic gene carriers and patients with Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Grimbergen YAM, Knol MJ, Bloem BR, Kremer BPH, Roos RAC & Munneke M (2008), Falls and gait disturbances in Huntington's disease.
- Bacos K, Bjorkqvist M, Petersen A, Luts L, Maat-Schieman MLC, Roos RAC, Sundler F, Brundin P, Mulder H & Wierup N (2008), Islet beta-cell area and hormone expression are unaltered in Huntington's disease, Histochemistry and Cell Biology 129(5).
- Youssov K, Roos RAC & Bachoud-Levi AC (2008), Assessment of advanced Huntington's disease patients with the Late-UHDRS: A pilot study, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T & Roos RAC (2008), Weight loss in Huntington's disease is related to the number of CAG repeats, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Aziz NA, van Belzen MJ & Roos RAC (2008), Intergenerational CAG repeat instability is highly heritable in Huntington's disease, Journal of Medical Genetics 45(11).
- van Oostrom J, Dekker M, Willemsen ATM, de Jong BM, Roos RAC & Leenders KL (2008), Changes in striatal dopamine D2 receptor binding in preclinical Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 79.
- Roos R.A.C. (2007), Chorea and Huntington's disease. In: Wolters E.C., Laar T. van & Berendse H.W. (Eds.), Parkinsonism and related disorders. Parkinsonism & Related Disorders. Amsterdam: VU University Press. 393-401.
- Aziz NA, Swaab DF, Pijl H & Roos RAC (2007), Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: Clinical consequences and therapeutic implications, Reviews in the Neurosciences 18(3-4).
- Munneke M, Keus SHJ, Nijkrake M, Kwakkel G, Berendse HW, Roos R, Borm GF & Bloem BR (2007), ParkNet: A multifaceted strategy to implement practice guidelines for physiotherapy in Parkinson's disease, Parkinsonism and Related Disorders 13.
- Munneke M, Nijkrake MJ, Keus SHJ, Lim IIK, Borm GF, van der Wilt GJ, Roos RAC, Kwakkel G, Berendse HW & Bloem BR (2007), Efficiency of physiotherapy in Parkinson's disease: The ParkNet trial, Movement Disorders 22.
- Kaptein AA, Scharloo M, Helder DI, Snoei L, van Kempen GMJ, Weinman J, van Houwelingen JC & Roos RAC (2007), Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptions, Quality of Life Research 16(5).
- Witjes-Ane MNW, Mertens B, van Vugt JPP, Bachoud-Levi AC, van Ommen GJB & Roos RAC (2007), Longitudinal evaluation of "Presymptomatic" carriers of Huntington's disease, Journal of Neuropsychiatry and Clinical Neurosciences 19(3).
- de Pril R, Fischer DF, Roos RAC & van Leeuwen FW (2007), Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases, Molecular and Cellular Neuroscience 34(1).
- Maat-Schieman M, Roos R, Losekoot M, Dorsman J, Welling-Graafland C, Hegeman-Kleinn I, Broeyer F, Breuning M & van Duinen S (2007), Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease, Brain Pathology 17(1).
- Keus SHJ, Nijkrake M, Bloem BR, Kwakkel G, Berendse HW, Roos R, Borm GF & Munneke M (2007), ParkNet implementation: Evaluation of health benefits, Parkinsonism and Related Disorders 13.
- Nishitsuji K, Tomiyama T, Ishibashi K, Kametani F, Ozawa K, Okada R, Maat-Schieman ML, Roos RAC, Iwai K & Mori H (2007), Cerebral vascular accumulation of dutch-type A beta 42, but not wild-type A beta 42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type, Journal of Neuroscience Research 85(13).
- van der Hiele K, Jurgens CK, Vein AA, Reijntjes RHAM, Witjes-Ane MNW, Roos RAC, van Dijk G & Middelkoop HAM (2007), Memory activation reveals abnormal EEG in preclinical Huntington's disease, Movement Disorders 22(5).
- Roos RAC & Aziz NA (2007), Hypocretin-1 and secondary signs in Huntington's disease, Parkinsonism and Related Disorders 13.
- van Oostrom JCH, Sijens PE, Roos RAC & Leenders KL (2007), 1H magnetic resonance spectroscopy in preclinical Huntington disease, Brain Research 1168.
- Smith R, Chung HF, Rundquist S, Maat-Schieman MLC, Colgan L, Englund E, Liu YJ, Roos RAC, Faull RLM, Brundin P & Li JY (2006), Cholinergic neuronal defect without cell loss in Huntington's disease, Human Molecular Genetics 15(21).
- Cong SY, Pepers BA, Roos RAC, van Ommen GJB & Dorsman JC (2006), Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis, Experimental Neurology 199(2).
- Wintrebert CMA, Zwinderman AH, Maat-Kievit A, Roos RA & van Houwelingen HC (2006), Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease, Statistics in Medicine 25(18).
- Zhang-Nunes SX, Maat-Schieman MLC, van Duinen SG, Roos RAC, Frosch MP & Greenberg SM (2006), The cerebral beta-amyloid angiopathies: Hereditary and sporadic, Brain Pathology 16(1).
- Montagne B, Kessels RPC, Kammers MPM, Kingma E, de Haan EHF, Roos RAC & Middelkoop HAM (2006), Perception of emotional facial expressions at different intensities in early-symptomatic Huntington's disease, European Neurology 55(3).
- Kaptein AA, Helder DI, Scharloo M, Van Kempen GMJ, Weinman J, Van Houwelingen HJC & Roos RAC (2006), Illness perceptions and coping explain well-being in patients with Huntington's disease, Psychology and Health 21(4).
- Cong SY, Pepers BA, Roos RAC, Van Ommen GJB & Dorsman JC (2005), Epitope mapping of monoclonal antibody 4C8 recognizing the protein Huntingtin, Hybridoma 24(5).
- Maat-Schieman M, Roos R & van Duinen S (2005), Hereditary cerebral hemorrhage with amyloidosis-Dutch type, Neuropathology 25(4).
- Petersen A, Gil J, Bjorkqvist M, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Roos RAC, Sundler F, Mulder H & Brundin P (2005), Orexin loss in Huntington's disease, Human Molecular Genetics 14(1).
- van Oostrom JCH, Maguire RP, Verschuuren-Bemelmans CC, van der Duin LV, Pruim J, Roos RAC & Leenders KL (2005), Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease, Neurology 65(6).
- Schillevoort I, Herings RMC, Hugenholtz GWK, de Boer A, Nolen WA, Roos RAC & Leufkens HGM (2005), Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: A case-control study, Pharmacy World and Science 27(4).
- Cong SY, Pepers BA, Evert BO, Rubinsztein DC, Roos RAC, van Ommen GJB & Dorsman JC (2005), Mutant huntingtin represses CBP, but not p300, by binding and protein degradation, Molecular and Cellular Neuroscience 30(4).
- Cong SY, Pepers BA, Evert BO, Rubinsztein DC, Roos RAC, van Ommen GJB & Dorsman JC (2005), Mutant huntingtin represses CBP, but not p300, by binding and protein degradation, Molecular and Cellular Neuroscience 30(1).
- Jurgens CK, Witjes-Ane MNW, van Vught JPP, Middelkoop HAM & Roos RAC (2005), Decreased performances on psychomotor tasks in Huntington's "presymptomatic'' carriers are due to subtle changes in both motor and cognitive functioning, Journal of Neurology, Neurosurgery and Psychiatry 76.
- de Pril R, Fischer DF, Maat-Schieman MLC, Hobo B, de Vos RAI, Brunt ER, Hol EM, Roos RAC & van Leeuwen FW (2004), Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases, Human Molecular Genetics 13(16).
- van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ & de Boer A (2004), Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?, Pharmacy World and Science 26(5).
- Timman R, Roos R, Maat-Kievit A & Tibben A (2004), Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test, Health Psychology 23(2).
- Maat-Schieman MLC, Yamaguchi H, Hegeman-Kleinn IM, Welling-Graafland C, Natte R, Roos RAC & van Duinen SG (2004), Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type, Acta Neuropathologica 107(5).
- van Vugt JPP, Piet KKE, Vink LJ, Siesling S, Zwinderman AH, Middelkoop HAM & Roos RAC (2004), Objective assessment of motor slowness in Huntington's disease: Clinical correlates and 2-year follow-up, Movement Disorders 19(3).
- Spliethoff-Kamminga NGA, Zwinderman AH, Springer MP & Roos RAC (2003), Psychosocial problems in Parkinson's disease: Evaluation of a disease-specific questionnaire, Movement Disorders 18(5).
- Bornebroek M, De Jonghe C, Haan J, Kumar-Singh S, Younkin S, Roos R & Van Broeckhoven C (2003), Hereditary cerebral hemorrhage with amyloidosis dutch type (A beta PP 693): decreased plasma amyloid-beta 42 concentration.
- Witjes-Ane MNW, Vegter-van der Vlis M, van Vugt JPP, Lanser JBK, Hermans J, Zwinderman AH, van Ommen GJB & Roos RAC (2003), Cognitive and motor functioning in gene carriers for Huntington's disease: A baseline study, Journal of Neuropsychiatry and Clinical Neurosciences 15(1).
- Spliethoff-Kamminga NGA, Zwinderman AH, Springer MP & Roos RAC (2003), A disease-specific psychosocial questionnaire for Parkinson's disease caregivers, Journal of Neurology 250(10).
- van Vugt JPP, Stijl M, Roos RAC & van Dijk JG (2003), Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease, Clinical Neurophysiology 114(2).
- Nijssen PCG, Ceuterick C, van Diggelen OP, Elleder M, Martin JJ, Teepen JLJM, Tyynela J & Roos RAC (2003), Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency, Brain Pathology 13(4).
- Schillevoort I, de Boer A, van der Weide J, Steijns LSW, Roos RAC, Jansen PAF & Leufkens HGM (2002), Antipsychotic-induced extrapyramidal syndromes and cytochrome P-450 2D6 genotype: a case-control study, Pharmacogenetics -London- 12(3).
- Helder DI, Kaptein AA, van Kempen GMJ, Weinman J, van Houwelingen HC & Roos RAC (2002), Living with Huntington's disease: Illness perceptions, coping mechanisms, and patients' well-being, British Journal of Health Psychology 7.
- Helder DI, Kaptein AA, Van Kempen GMJ, Weinman J, Van Houwelingen JC & Roos RAC (2002), Living with Huntington's disease: Illness perceptions, coping mechanisms, and spouses' quality of life, International Journal of Behavioral Medicine 9(1).
- Maat-Schieman M, van Duinen S, Roos R & Yamaguchi H (2002), Distribution of amyloid-beta (A beta) deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D), Neurobiology of Aging 23(1).
- Witjes-Ane MNW, Zwinderman AH, Tibben A, van Ommen GJB & Roos RAC (2002), Behavioural complaints in participants who underwent predictive testing for Huntington's disease, Journal of Medical Genetics 39(11).
- van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ & de Boer A (2002), Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment, European Journal of Clinical Pharmacology 58(2).
- Schillevoort I, van Puijenbroek EP, de Boer A, Roos RAC, Jansen PAF & Leufkens HGM (2002), Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports, International Clinical Psychopharmacology 17(2).
- Dorsman JC, Pepers B, Langenberg D, Kerkdijk H, Ijszenga M, den Dunnen JT, Roos RAC & van Ommen GJB (2002), Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells, Human Molecular Genetics 11(13).
- van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ & de Boer A (2002), Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users, Acta Neurologica Scandinavica 105(1).
- Nijssen PCG, Brusse E, Leyten ACM, Martin JJ, Teepen JLJM & Roos RAC (2002), Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunction, Movement Disorders 17(3).
- Maat-Kievit A, Losekoot M, Zwinderman K, Vlis MVVD, Belfroid R, Lopez F, van Ommen GJ, Breuning M & Roos R (2002), Predictability of age at onset in Huntington disease in the Dutch population, Medicine 81(4).
- van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ & de Boer A (2002), Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa, British Journal of Clinical Pharmacology 54(2).
- Ozawa K, Tomiyama T, Maat-Schieman ML, Roos RA & Mori H (2002), Enhanced A beta(40) deposition was associated with increased A beta(42/43) in cerebral vasculature with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D), Annals of the New York Academy of Sciences 977.
- Duisterhof M, Trijsburg RW, Niermeijer MF, Roos RAC & Tibben A (2001), Psychological studies in Huntington's disease: making up the balance, Journal of Medical Genetics 38(12).
- Schillevoort I, de Boer A, Herings RMC, Roos RAC, Jansen PAF & Leufkens HGM (2001), Antipsychotic-induced extrapyramidal syndromes - Risperidone compared with low- and high-potency conventional antipsychotic drugs, European Journal of Clinical Pharmacology 57(4).
- van de Vijver DAMC, Stricker BHC, Breteler MMB, Roos RAC, Porsius AJ & de Boer A (2001), Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease, Pharmacy World and Science 23(4).
- Cath DC, Spinhoven P, Van Woerkom TCAM, Van de Wetering BJM, Hoogduin CAL, Landman AD, Roos RAC & Rooijmans HGM (2001), Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: Which symptoms discriminate?, Journal of Nervous and Mental Disease 189(4).
- Natte R, Maat-Schieman MLC, Haan J, Bornebroek M, Roos RAC & van Duinen SG (2001), Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles, Annals of Neurology 50(6).
- Maat-Kievit A, Helderman-van den Enden P, Losekoot M, de Knijff P, Belfroid R, Vegter-van der Vlis M, Roos R & Breuning M (2001), Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease, American Journal of Medical Genetics 105(8).
- Cath DC, Spinhoven P, Hoogduin CAL, Landman AD, van Woerkom TCAM, van de Wetering BJM, Roos RAC & Rooijmans HGM (2001), Repetitive behaviors in Tourette's syndrome and OCD with and without ties: what are the differences?, Psychiatry Research 101(2).
- Schillevoort I, de Boer A, Herings RMC & Roos RAC (2001), Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine, Annals of Pharmacotherapy 35(12).
- van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ & de Boer A (2001), Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records, Pharmacoepidemiology and Drug Safety 10(6).
- van Vugt JPP, Siesling S, Piet KKE, Zwinderman AH, Middelkoop HAM, van Hilten JJ & Roos RAC (2001), Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease, Movement Disorders 16(3).
- Helder DI, Kaptein AA, van Kempen GMJ, van Houwelingen JC & Roos RAC (2001), Impact of Huntington's disease on quality of life, Movement Disorders 16(2).
- Siesling S, Vegter-van de Vlis M, Losekoot M, Belfroid RDM, Maat-Kievit JA, Kremer HPH & Roos RAC (2000), Family history and DNA analysis in patients with suspected Huntington's disease.
- Maat-Schieman MLC, Yamaguchi H, van Duinen SG, Natte R & Roos RAC (2000), Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis.
- Cath DC, Spinhoven P, van de Wetering BJM, Hoogduin CAH, Landman AD, van Woerkom TCAM, Roos RAC & Rooijmans HGM (2000), The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder.
- Yamaguchi H, Maat-Schieman MLC, van Duinen SG, Prins FA, Neeskens P, Natte R & Roos RAC (2000), Amyloid beta protein (A beta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects.
- Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A & Roos R (2000), Paradox of a better test for Huntington's disease, Journal of Neurology, Neurosurgery and Psychiatry 69(5).
- Ane MNW, Vegter-van der Vlis M, van Vugt JPP, Lanser JBK, Hermans J, Zoeteweij MW & Roos RAC (2000), Relationship between cognitive and motor functioning in gene-carriers for Huntington's Disease, Journal of Medical Genetics 37.
- de Boo GM, Tibben A, Hermans J, Jennekens-Schinkel A, Maat-Kievit A & Roos RAC (1999), Memory and learning are not impaired in presymptomatic individuals with an increased risk of Huntington's disease.
- voorzitter adviesraad
- Executive committee
- Adviseur